RNA-binding proteins in yeast mitochondria by Deumer, Claudia D.
 
 
 
 
RNA-binding proteins in yeast mitochondria 
 
 
 
Dissertation 
 
zur  Erlangung des akademischen Grades 
Doktor der Naturwissenschaften 
(Dr. rer. nat.) 
 
eingereicht an der 
Fakultät Mathematik und Naturwissenschaften 
der Technischen Universität Dresden 
 
von 
Claudia D. Deumer 
aus Gera 
 
 
 
 
 
Gutachter:   1. Prof. Dr. Gerhard Rödel 
    2. Prof. Dr. Leslie A. Grivell 
    3. Prof. Dr. Michael Göttfert 
 
 
 
Eingereicht am:  12.07.2002 
Tag der Verteidigung: 09.10.2002 
 
  
 
 
Part of this work was published: 
 
Abstracts: 
 
de Jong, L., Deumer, C. and van der Spek, H. (2000) 
Idh is a translational repressor. 
FEBS Advanced Course 2000-03 
 
 
Deumer, C., van der Spek, H.  and Rödel, G. (2001) 
RNA-binding proteins in yeast mitochondria. 
Yeast 18, 03-04 
Contents 
  
Abbrevations ........................................................................................................................................................... 1 
 
Aim of the work ...................................................................................................................................................... 3 
 
1 INTRODUCTION........................................................................................................................................... 4 
 
1.1 Bifunctional proteins ............................................................................................................................... 4 
1.1.1 Aconitase ......................................................................................................................................... 4 
 
1.2 Mitochondria ........................................................................................................................................... 6 
1.2.1 Regulation of mitochondrial function.............................................................................................. 7 
1.2.1.1 Organisation of the respiratory chain........................................................................................... 8 
1.2.1.2 Organisation of the Krebs cycle................................................................................................... 9 
1.2.2 Regulation of mitochondrial translation ........................................................................................ 11 
1.2.2.1 Specific translational factors...................................................................................................... 13 
1.3 Isocitrate dehydrogenase ....................................................................................................................... 15 
 
2 MATERIALS AND METHODS .................................................................................................................. 19 
 
2.1 Materials ................................................................................................................................................ 19 
2.1.1 Instruments .................................................................................................................................... 19 
2.1.2 Materials ........................................................................................................................................ 19 
2.1.3 Kits ................................................................................................................................................ 20 
2.1.4 Antibodies...................................................................................................................................... 20 
2.1.5 Strains ............................................................................................................................................ 21 
2.1.5.1  Escherichia coli (E. coli) .......................................................................................................... 21 
2.1.5.2  Saccharomyces cerevisiae (S. cerevisiae)................................................................................. 21 
2.1.6 Media............................................................................................................................................. 22 
2.1.6.1  E. coli-media............................................................................................................................. 22 
2.1.6.2  S. cerevisiae-media ................................................................................................................... 22 
2.1.6.3  Buffers ...................................................................................................................................... 23 
2.1.6.4  Solutions for Bradford assay .................................................................................................... 23 
2.1.6.5  Solutions for SDS-PAGE ......................................................................................................... 23 
2.1.6.6  Solutions for silver staining ...................................................................................................... 24 
2.1.6.7  Solutions for Western blot ........................................................................................................ 24 
2.1.6.8  Solutions for band shift assay ................................................................................................... 25 
2.1.7 Vectors........................................................................................................................................... 25 
2.1.8 Recombinant plasmids................................................................................................................... 26 
2.1.9 Primers........................................................................................................................................... 26 
2.1.10 Recombinant plasmids of these work ............................................................................................ 27 
 
2.2 Methods ................................................................................................................................................. 28 
2.2.1 Plasmids......................................................................................................................................... 28 
2.2.2 Sequencing .................................................................................................................................... 29 
2.2.3 Transformation of yeast cells......................................................................................................... 30 
2.2.4 Isolation of yeast mitochondria ..................................................................................................... 30 
2.2.4.1  Large scale preparation of mitochondria (modified procedure of Grivell , 1971) .................... 30 
2.2.4.2  Preparation of mitochondria (modified procedure of McKee, 1984)........................................ 31 
2.2.5 Purification of mitochondrial proteins........................................................................................... 31 
2.2.6 Affinity purification of recombinant mitochondrial proteins......................................................... 32 
2.2.7 Determination of Citrate synthase activity (Srere et al., 1963)...................................................... 33 
2.2.8 Determination of Malate dehydrogenase activity (McAlister-Henn and Thompson, 1987).......... 33 
2.2.9 In vitro transcription ...................................................................................................................... 34 
2.2.10 In vitro RNA-protein binding assay .............................................................................................. 35 
2.2.11 In vitro translation ......................................................................................................................... 36 
2.2.12 Determination of the protein concentration ................................................................................... 36 
2.2.13 Western blot analysis..................................................................................................................... 36 
2.2.14 Blue native gel-electrophoresis...................................................................................................... 37 
 
Contents 
  
3 RESULTS...................................................................................................................................................... 38 
 
3.1 Characterisation of Idh1 mutant proteins............................................................................................... 38 
3.1.1 Complementation analysis of idh1 mutants................................................................................... 38 
3.1.2 Influence of idh1 mutations on protein stability ............................................................................ 39 
3.1.3 Effect of idh1 mutations on mitochondrial translation products.................................................... 40 
 
3.2 Evidence for occurrence of Idhp in a high molecular weight complex ................................................. 42 
 
3.3 Identification of RNA-binding activities in idh2 null mutant strains .................................................... 43 
 
3.4 Effect of cit1 and mdh1 null mutations on mitochondrial translation products ..................................... 46 
 
3.5 Functional analysis of C-terminally tagged forms of Cit1p and Mdh1p ............................................... 48 
3.5.1 Complementation analysis of Cit1p and Mdh1p ........................................................................... 48 
3.5.2 Affinity purification of Cit1p and Mdh1p ..................................................................................... 49 
3.5.3 Enzymatic activity of Cit1p and Mdh1p........................................................................................ 51 
3.5.4 Analysis of protein-protein interactions of Cit1p and Mdh1p ....................................................... 51 
3.5.5 Cit1p-His6 and Mdh1p-His6 bind to COX2 leader RNA................................................................ 53 
 
3.6 Specificity of Cit1p/Mdh1p RNA-binding ............................................................................................ 54 
 
3.7 Influence of cofactors and substrates on Cit1p/Mdh1p RNA-binding................................................... 57 
 
4 DISCUSSION ............................................................................................................................................... 60 
 
4.1 Characterisation of Idhp by mutant forms ............................................................................................. 60 
 
4.2 Localisation of Idhp............................................................................................................................... 64 
 
4.3 RNA-binding properties of Cit1p and Mdh1p....................................................................................... 65 
 
4.4 Effects of Cit1p and Mdh1p on mitochondrial translation .................................................................... 67 
 
4.5 Localisation of Cit1p and Mdh1p .......................................................................................................... 68 
 
4.6 Specifity of RNA-binding ..................................................................................................................... 70 
 
4.7 Influence of cofactors and substrates on RNA-binding ......................................................................... 73 
 
4.8 Role of Cit1p and Mdh1p as RNA-binding proteins ............................................................................. 76 
 
5 SUMMARY .................................................................................................................................................. 78 
 
6      REFERENCES.............................................................................................................................................. 80 
 
Danksagung........................................................................................................................................................... 95 
 
Curriculum vitae.................................................................................................................................................... 96 
 
Versicherung ......................................................................................................................................................... 97 
 
 
 
Abbrevations 
 1 
 
Abbreviations 
 
Ace Acetate 
AMP Adenosine monophosphate 
APS Ammoniumperoxidisulfat 
ATP Adenosine triphosphate 
c Cytosolic 
COB Cytochrome b 
COX Cytochrome c oxidase  
cpm Counts per minute 
C-terminus Carboxyl-terminus 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonuleic acid 
dNTP Deoxynucleosidtriphosphate 
DTT Dithiothreitol 
EDTA Ethylendiamine-tetraacetic acid 
EGFP Enhanced green fluorescent protein 
Gly Glycerol 
HA Heme agglutinine 
HRP Horseradish-peroxidase 
IM Inner membrane 
IMS Intermembrane space 
kDa Kilodalton 
min Minutes 
mRNA Messenger RNA 
NAD+ Nicotinamide adenine dinucleotide 
NADH Nicotinamide adenine dinucleotide (reduced form of NAD+) 
N-terminus Amino-terminus 
nt Nucleotides 
OD Optical density 
OM Outer membrane 
ORF Open reading frame 
PAGE Polyacrylamide gel-electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PMSF Phenylmethylsulfonyl fluoride 
poly(A) Poly adenylate 
PVDF Polyvinylidene difluoride 
RNA Ribonucleic acid 
RT Room temperature 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel-electrophoresis 
TEMED N,N,N',N'-Tetramethylethylenediamine 
TM Transmembrane 
tRNA Transfer RNA 
Tris Tris(hydroxymethyl)aminomethane 
UTP Uridine 5’-triphosphate 
UTR Untranslated region 
v/v Volume per volume 
w/v Weight per volume 
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Amino acids 
 
      
A Ala alanine M Met methionine 
C Cys cysteine N Asn asparagine 
D Asp asparagine P Pro proline 
E Glu glutamate Q Gln glutamine 
F Phe phenylalanine R Arg arginine 
G Gly glycine S Ser serine 
H His histidine T Thr threonine 
I Ile isoleucine V Val valine 
K Lys lysine W Trp tryptophan 
L Leu leucine Y Tyr tyrosine 
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Aim of the work 
 
Mitochondrial biogenesis and function are complex biological processes that depend on the 
coordinate expression of (hundreds of) nuclear genes and the mitochondrial genome. For 
example the translation of mitochondrial mRNAs encoding subunits of the respiratory chain is 
activated by distinct proteins encoded in the nucleus (Fox, 1996). These mRNA-specific 
translational activators are associated with the inner mitochondrial membrane, recognize sites 
in the 5’-untranslated leaders of their target mRNAs and interact functionally with the 
mitochondrial ribosomal small subunit. Membrane-bound activators may be an adaptation for 
targeting the synthesis of mitochondrially encoded membrane proteins to the membrane. In 
addition, activation of translation of specific mRNAs is probably a rate-limiting step used to 
modulate the expression of mitochondrial genes in response to environmental conditions. 
Action of the various translational activators should be considered in relation to that of the 
bifunctional Krebs cycle enzyme NAD+-dependent isocitrate dehydrogenase (Idhp). Idhp 
inhibits mitochondrial translation (de Jong et al., 2000) probably mediated by binding to the 
5’-UTRs of all mitochondrial mRNAs (Dekker et al., 1992). In this way Idhp could 
coordinately control translation of all mitochondrially encoded proteins. 
This work will focus on the further characterisation of Idhp and of the Krebs cycle enzymes 
citrate synthase 1 (Cit1p) and malate dehydrogenase 1 (Mdh1p) both of which have been 
identified as RNA-binding proteins. Besides analysing their effects on mitochondrial 
translation and their organisation in protein complexes the work focuses on the 
characterisation of the RNA-binding properties of recombinant Cit1p and Mdh1p. The 
influence of cofactors and substrates on RNA-binding will be analysed in order to reveal a 
possible link between the enzymatic function and the property of RNA-binding. 
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1 INTRODUCTION 
1.1 Bifunctional proteins 
Over the past few years, it has been discovered that a number of enzymes has not only a 
metabolic role in the cell but is also able to bind mRNAs. In that way they are involved in 
either translational regulation or in control of mRNA stability. These enzymes represent a 
growing family of proteins with dual functions. To give an impression about the diversity of 
the enzymatic function and the key regulatory role in a biochemical pathway, a short review 
on aconitase and its importance in iron homeostasis is given. 
1.1.1 Aconitase 
The most extensively studied member of bifunctional enzymes is the cytosolic (c) aconitase 
(summarised in Table 1). Its RNA-binding activity depends on the iron concentration in the 
cell. Therefore it is also called iron-responsive element-binding protein (IRE-BP). The IRE-
BP binds to specific stem-loop RNA structures known as iron-responsive elements (IREs). 
IREs are present in a variety of cellular mRNAs encoding proteins involved in iron uptake 
(transferrin receptor (TfR)), storage (ferritin) and utilization (erythroid 5-aminolevulinate 
synthase (eALAS)) (Eisenstein et al., 1993; Hentze and Kuhn, 1996). Expression of these 
genes is regulated by interaction with the IRE-BP via translational regulation (for ferritin and 
eALAS mRNAs) or by controlling mRNA stability (for TfR mRNA), depending on the 
location of the IRE (Eisenstein et al., 1993; Hentze and Kuhn, 1996; Theil, 1998). IREs 
involved in translational regulation are located in the 5’-UTR of the mRNAs, while IREs 
involved in mRNA stability are located in the 3’-UTR of the mRNAs. The function of IRE-
BP is determined by the presence or absence of an Fe-S cluster: it shows aconitase activity 
when the Fe-S cluster is present, and acts as an RNA-binding protein when the protein lacks 
this cluster (Kaptain et al., 1991; Kennedy et al., 1992; Haile et al., 1992; Eisenstein et al., 
1993). Aconitase activity and IRE-binding activity are mutually exclusive, and 
interconversion between the two activities is determined by the intracellular Fe concentration. 
Fe-S cluster assembly occurs under conditions of excess iron, converting IRE-BP to c-
aconitase and stimulating synthesis of ferritin and eALAS synthesis, while TfR synthesis is 
repressed. Iron depletion promotes cluster disassembly, hence conversion of c-aconitase to 
IRE-BP, and repression of ferritin and eALAS synthesis, while stimulating TfR expression. 
Introduction 
   5 
Subsequently, another member of the iron regulatory protein family was identified. In the 
following this protein is referred to iron regulatory protein 2 (IRP2), while IRE-BP is the iron 
regulatory protein 1 (IRP1). IRP1 and IRP2 have a high sequence identity except for a 73-
amino acid insertion unique to IRP2. In contrast to IRP1, IRP2 has only IRE-binding activity 
and is regulated by the degradation of the protein when cells are iron-repleted (Guo et al., 
1995; Iwai et al., 1995, 1998; Eisenstein et al., 1997). 
The control of IRE-BP activity is also subject to regulation by other factors. Both IRP1 and 
IRP2 are phosphorylated in vivo, indicating that their function may be integrated into more 
general metabolic signals (Eisenstein et al., 1993; Schalinske and Eisenstein, 1996). Exposure 
of cells to nitric oxide (NO) or hydrogen peroxide (H2O2) enhances IRE-binding activity and 
inhibits c-aconitase activity in animal cells (Hentze and Kuhn, 1996). Both NO and H2O2 
cause Fe-S cluster disruption (Kennedy et al., 1997; Brazzolotto et al., 1999). The 
consequence of these regulatory processes would be to modulate the expression of genes 
regulated by IRP1 and aconitase activity, similar to the effect of iron on IRP1. 
Functional IREs are also identified in the 5’-UTRs of the mRNAs encoding the Krebs cycle 
enzymes aconitase (porcine) (Dandekar et al., 1991) and the iron-sulfur protein subunit of 
succinate dehydrogenase (Sdhp) in Drosophila melanogaster (Gray et al., 1996). 
Translational repression of these genes is mediated by IRP1, thereby identifying a regulatory 
link between the control of iron homeostasis by the IRE/IRP system and the mitochondrial 
Krebs cycle (Dandekar et al., 1991; Gray et al., 1996). IRP-mediated changes in 
mitochondrial aconitase (and Sdhp) abundance may represent a means to modulate the 
availability of citrate in cellular iron homeostasis. Citrate can bind iron as well as promote 
iron uptake and release from mammalian cells. Iron citrate is a major component of the non-
transferrin-bound iron pool present in the plasma in some forms of iron overload (Grootveld 
et al., 1989), suggesting the possibility that it may be released by some tissues such as the 
liver. Furthermore, citrate influences the binding and/or release of iron to and from ferritin 
and transferrin. Given the known function of IRP1 and IRP2 in modulating iron uptake and 
storage, it is reasonable to assume that mediation of mitochondrial aconitase expression by 
IRP represents a directed effort to modulate the role of citrate in cellular trafficking. 
RNA-binding activity has also been attributed to other “regular” enzymes, including 
thymidilate synthase, catalase, glyceraldehyde-3-phosphate dehydrogenase and glutamate 
dehydrogenase (Hentze, 1994). None of these proteins contain recognizable RNA-recognition 
motifs, all of them do, however, contain a (di-)nucleotide binding domain (Rossmann fold, 
Rossmann, 1975). RNA-binding of some of these enzymes, e.g. glyceraldehyde-3-phosphate 
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dehydrogenase, glutamate dehydrogenase, catalase and thymidylate synthase, could be 
competed by NAD(H), NADP(H) or ATP, suggesting that the Rossmann fold might serve as 
an RNA-binding domain and indicating that the enzymatic function and RNA-binding are 
mutually exclusive (Chu et al., 1993; Nagy and Rigby, 1995; Clerch et al., 1996; Bringaud et 
al., 1997). These observations led to the hypothesis that the RNA-binding domains present in 
these enzymes evolved from a (di-)nucleotide binding site, or vice versa (Hentze, 1994). 
 
Table 1: Properties of aconitase 
RNA-binding 
enzyme 
Enzymatic 
function 
Target RNA Putative RNA-
binding 
function 
Modulation of 
RNA-binding 
Reference 
Aconitase/IRP1 
 
Conversion of 
citrate into 
isocitrate 
IRE in: 
•  3’ TfR mRNA 
•  5’ Ft mRNA 
•  5’ eALAS 
  mRNA 
•  5’ mt aconitase 
  mRNA 
•  5’ SDH mRNA 
Protection of 
mRNA 
Translational 
regulation 
Iron 
concentration 
NO, H2O2 
concentration 
Hentze and 
Kuhn, 1996 
1.2 Mitochondria 
Mitochondria are near ubiquitous organelles of eukaryotic cells. Their assembly and function 
result from a collaboration between gene products encoded by mitochondrial and nuclear 
genomes. Most of the proteins which reside in the mitochondrion are nuclear gene products 
accounting for about 90 % of the protein mass of the mitochondrion. These proteins are 
translated in the cytoplasm and subsequently posttranslationally transported into the 
mitochondrion. They play key roles in mitochondrial transcription and translation, 
mitochondrial lipid and heme synthesis, substrate oxidation by the Krebs cycle and 
mitochondrial electron transport and oxidative phosphorylation. In short, these proteins play 
roles in all aspects of mitochondrial function, and they are distributed in all four 
mitochondrial compartments (inner and outer membrane, matrix and intermembrane space). 
In contrast, the mitochondrial genome specifies only a few proteins, which reside mainly in 
the inner mitochondrial membrane. But the nuclear and the mitochondrial genomes do not 
only interact in the described way. The mitochondrial genome can also give a feedback to the 
Introduction 
   7 
nucleus and affect the expression of nuclear genes for mitochondrial (and other) proteins 
(Parikh et al., 1987; Farrell et al., 1990). This communication pathway by which the 
mitochondrion “talks to” the nucleus is not well understood but is likely to be fundamentally 
different from that of the communication pathway from the nucleus to the mitochondrion. 
Probably it involves metabolic signals and one or more signal transduction pathways that 
function across the inner mitochondrial membrane. 
1.2.1 Regulation of mitochondrial function 
Several factors such as oxygen level, carbon source and metal ions are known to alter 
mitochondrial protein levels and/or function. This regulation is important for adjusting the 
energy producing capacity of a cell and especially developed in the regulation of respiratory 
activity of yeast mitochondria. Respiration undergoes dramatic changes in response to the 
environmental factors oxygen and glucose. Under anaerobic conditions or when grown on 
glucose as carbon source, synthesis of the respiratory complexes and of the ATPase is 
repressed. As a result mitochondria are almost totally devoid of the ability to oxidize 
nonfermentable substrates and to generate ATP by oxidative phosphorylation (Mahler et al., 
1975). When yeast cells are grown on a carbon source that requires mitochondrial function 
the steady-state levels of most mitochondrial mRNAs increase about 5-fold compared with 
growth on glucose medium (Müller and Getz, 1986). In contrast to the steady-state level of 
RNAs, the apparent rates of synthesis of the major mitochondrial gene products (measured by 
in vivo labelling in the presence of cycloheximide) vary over a wider range. For example, 
Cox1p, Cox2p, Cox3p, and cytochrome b were at least 19 times more slowly labelled in 
anaerobically grown than in aerobically grown cells (Woodrow and Schatz, 1979). Taken 
together, these findings suggest that modulation of mitochondrial gene expression in response 
to oxygen occurs at least partially at the translational level. Similarly, the release of glucose 
repression greatly stimulates translation of Cox3p (Falcone et al., 1983), but has little effect 
on its mRNA level (Zennaro et al., 1985). This apparent translational modulation is generally 
paralleled by the expression of nuclear genes coding components of the mitochondrial 
translation system. However, these genes are not under tight coordinate regulation and are 
probably controlled by several different mechanisms. 
As known from the IRE-BP (see chapter 1.1.1) some of mitochondrial functions can be 
regulated by metals like iron. Iron modulates the expression of the Krebs cycle enzyme 
aconitase via a translational mechanism involving iron regulatory proteins and interestingly, 
as shown recently, iron also affects three other Krebs cycle enzymes, namely citrate synthase, 
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isocitrate dehydrogenase and succinate dehydrogenase (Oexle et al., 1999). Whereas the SDH 
mRNA of Drosophila melanogaster contains a functional IRE, such an element has not been 
identified so far in the untranslated regions of CIT or IDH mRNA. Therefore the enzymatic 
activities of these proteins apparently are not regulated by the IRP/IRE system. Since the 
Krebs cycle provides NADH for oxidative phosphorylation to generate the proton gradient for 
ATP formation, influences on Krebs cycle enzymes can cause broad changes. Indeed iron 
supplementation leads to increased formation of reducing equivalents (NADH) by the Krebs 
cycle and thus results in increased mitochondrial oxygen consumption and ATP formation via 
oxidative phosphorylation (Oexle et al., 1999). 
These results point to an interaction of both oxygen supply and cellular energy metabolism 
with iron homeostasis and give an idea of the complex regulation by environmental factors. 
1.2.1.1  Organisation of the respiratory chain 
The mitochondrial electron transport chain is composed of four complexes embedded in the 
mitochondrial inner membrane: complex I (NADH-ubiquinone oxidoreductase), complex II 
(succinate-ubiquinone oxidoreductase), complex III (ubiquinol cytochrome c reductase) and 
complex IV (cytochrome c oxidase). In contrast to most eukaryotes, the yeast Saccharomyces 
cerevisiae (S. cerevisiae) does not possess a complex I, but rather contains two NADH 
dehydrogenases associated with the inner membrane (de Vries and Marres, 1987; Luttik et al., 
1998). The respiratory chain complexes are electronically linked by ubiquinone and 
cytochrome c. They act in sequence to accept reducing equivalents from NADH or FADH2 
and transfer them through a series of oxidation-reduction reactions to O2, resulting in the 
formation of water and the generation of proton and ion gradients across the inner 
mitochondrial membrane. These latter gradients are used to drive the synthesis of ATP by 
another multimeric protein, complex V (ATP synthase). Investigations concerning the 
mobility of ubiquinone and cytochrome c showed, that these electron carriers do not diffuse 
freely through or along the membrane (Boumans et al., 1998). From these findings it was 
concluded that, at least in yeast mitochondria, the respiratory chain is physically connected 
and may act as a functional unit. Cruciat et al. (2000) showed that complex III is associated 
with complex IV. Physical association of the mitochondrial respiratory chain complexes may 
serve to enhance the flow of electrons between these complexes and to reduce the dependency 
on random diffusion of the electron carriers ubiquinone and cytochrome c. Indeed formation 
of a supracomplex between complexes III and IV in Paracoccus denitrificans has been 
demonstrated to significantly enhance electron transfer between these complexes (Berry and 
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Trumpower, 1985). Furthermore Schägger and Pfeiffer (2000) showed that cytochrome c 
oxidase of S. cerevisiae is bound to cytochrome c reductase which exists in three forms: the 
free dimer, and two supercomplexes comprising an additional one or two complex IV 
monomers. The distribution between these forms depends on the carbon source. In 
mammalian mitochondria, complex I and III can also form a supercomplex containing up to 
four copies of complex IV. These data guided the authors to develop a model for a network of 
respiratory chain complexes called “respirasome” (Schägger and Pfeiffer, 2000). Such 
multienzyme complexes mediate substrate channelling which allows transfer of an 
intermediate to a specific enzyme without competition by other enzymes. A major advantage 
of substrate channelling is the use of a localised substrate molecule (potential candidates are 
ubiquinone and cytochrome c), which makes a reaction independent of a substrate pool. The 
absence of a pool function for cytochrome c in yeast indicates tight substrate channelling 
which consequently leads to catalytic enhancement, sequestration of reactive intermediates 
and rapid intramolecular group transfer reaction (Fersht, 1999; Schägger and Pfeiffer, 2000). 
1.2.1.2  Organisation of the Krebs cycle 
The Krebs cycle plays a central role in anabolism by providing components for biosynthetic 
pathways and in catabolism by oxidative decarboxylation of metabolites. During the 
decarboxylation step the coenzyme NAD+ is reduced. These reducing equivalents are oxidised 
via the respiratory chain. Thus a coenzyme and its regeneration links two different pathways 
(Fig. 1). For the respiratory chain, an interaction of the enzymes with each other which allows 
the formation of highly organised enzyme complexes was outlined above (1.2.1.1). The 
kinetic advantage of such “organised enzymes” has also been demonstrated for the Krebs 
cycle (Robinson et al., 1987) while direct evidence for physical contacts between the Krebs 
cycle enzymes was only obtained for several enzymes: binding of malate dehydrogenase to 
complex I in beef heart mitochondria (Ovadi et al., 1994), channelling of oxaloacetate by 
malate dehydrogenase and citrate synthase (Lindbladh et al., 1994) and channelling of citrate 
by citrate synthase and aconitase (Velot and Srere, 2000). The observation that Citp behaves 
as an immobilized enzyme suggests its participation in a supramolecular complex (Haggie 
and Brindle, 1999). These data led to the development of the “metabolon” concept describing 
a possible Krebs cycle complex. Recently Grandier-Vazeille et al. (2001) presented results 
supporting this idea of a metabolon and indicating an interaction of the Krebs cycle with the 
respiratory chain. The authors detected in yeast a supramolecular complex containing two 
NADH dehydrogenases and four enzymes of the Krebs cycle, namely Mdh1p, Cit1p, Sdh1p 
Introduction 
and Fum1p (fumarate hydratase). Fum1p catalyses the metabolic step preceding Mdh1p 
suggesting a channelling between these enzymes, while Cit1p catalyses the metabolic step 
following Mdh1p indicating a channelling between these two enzymes, too. The assumption 
of Cit1p as a relatively immobilized protein (Haggie and Brindle, 1999) which is associated 
with a supramolecular complex was confirmed by its participation in the described NADH 
dehydrogenase complex. Sdh1p catalyses the step preceding Fum1p also indicating a 
channelling. The association of these proteins with the proteins of complex I may indicate 
NADH-channeling and besides the obvious functional connections may hint to physical 
contacts of Krebs cycle components and respiratory chain enzymes. 
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Fig. 1: Functional connection between respiratory chain and Krebs cycle  
The respiratory chain complexes are located in the mitochondrial inner membrane (IM), and 
the Krebs cycle enzymes in the mitochondrial matrix. Both pathways are linked by the 
coenzyme NAD+ and its regeneration. During the Krebs cycle NAD+ is reduced. The reducing 
equivalents NADH drive the respiratory chain where they will be oxidised.  
1.2.2 Regulation of mitochondrial translation 
Gene expression in yeast mitochondria is mainly regulated at the translational level (Pel and 
Grivell, 1994). By far most of the proteins known to be involved in expression of 
mitochondrial genes are required for translation while only a few have been shown to be 
necessary for transcription. 
Initiation of translation includes the sequential recruitment of a small and a large ribosomal 
subunit to the mRNA, to form a translation-competent ribosome at the appropriate initiation 
codon. In case of cytoplasmic mRNAs, it requires the participation of many eukaryotic 
initiation factors as well as the cap structure at the 5’-end and a poly(A) tail at the 3’-end of 
the mRNA. The 5’-cap, which is present on nearly all eukaryotic mRNAs, facilitates the 
initiation of translation while the poly(A) tail is thought to stabilise the mRNA by protecting 
it against degradation. The poly(A) tail gradually shortens in time, indicating that it may fix 
the half life of the mRNA. These mechanisms are not used in yeast mitochondrial mRNAs as 
they are uncapped (Christianson and Rabinowitz, 1983) and lack a poly(A) tail (Moorman et 
al., 1978). Although mitochondrial and eubacterial translation systems show many 
similarities, they also exhibit differences in the mechanism of translational initiation. In 
eubacteria, bin-ding and positioning of mRNA on the small ribosomal subunit depends on 
base pairing bet-ween a sequence in the 16S rRNA and a complementary sequence in the 5’-
untranslated region of the mRNA, known as the Shine-Dalgarno sequence (Gold, 1988). This 
kind of interaction seems unlikely in yeast mitochondria, since there are no obvious Shine-
Dalgarno sequences present in mitochondrial mRNAs. Moreover scanning for initiation 
codons by the ribosome, which is proposed for the cytosolic counterparts in eukaryotes 
(Kozak, 1983), seems unlikely to occur since the 5’-UTR of mitochondrial mRNAs often 
contain AUG initiation codons, short upstream open reading frames (uORFs) and stable 
secondary structures formed by short G+C rich clusters (Pel and Grivell, 1994). Stable 
secondary structures in leader sequences hinder the scanning by the 40S ribosomal subunit in 
both mammalian cells and yeast (Herrick et al., 1990; Kozak, 1991a; Vega Laso et al., 1993; 
Beelman and Parker, 1994; Sagliocco et al., 1994). uORFs are seldom found in cytosolic 
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transcripts of yeast and higher eukaryotes (Kozak, 1991b) where they can have a negative 
effect on the efficiency of translational initiation at the authentic start codon (Hinnebusch et 
al., 1988). In some cases uORFs might exhibit regulatory functions (Abastado et al., 1991). 
Therefore mitochondrial ribosomes can probably not reach the start codon by scanning of the 
untranslated leader RNAs, but rather bind at an internal site of the mRNA-leaders. The 
mechanism of this process is still unclear. Internal translational initiation has been shown for 
Picorna-viral RNA in eukaryotic cells using conserved structural domains in the 5’-UTR of 
the viral RNA genome. The Picornavirus RNA does not have a 5’-cap but has a long 
untranslated region at the 5’-end. This region forms stem-loop structures which interact with 
the 40S ribosomal subunit and initiate the cap-independent translation at the internal ribosome 
entry site (IRES) (Agol, 1991; Belsham and Sonenberg, 1996; Stewart and Semler, 1998; 
McCarthy, 2000). Izquierdo and Cuezva (2000) have shown for mammalian cells that the 
RNA of the nuclearly encoded β-subunit of the mitochondrial ATP-synthase is regulated by 
an enhancer sequence of 150 bp located in the 3’-untranslated region. By means of 
transcription of a reporter gene it was shown that this enhancer sequence initiates 
transcriptional start independent of its localisation at the 5’- or the 3’-end. If the enhancer 
sequence is located at the 3’-end, an interaction between the 5’- and the 3’-end is required 
during translation initiation (Izquierdo and Cuezva, 2000). In addition the 5’-leader sequences 
of YAP1- and p150-mRNA of S. cerevisiae also contain functional IRES elements (Zhou et 
al., 2001). 
A ribosome binding site with a fixed position relative to the start site of translation, like those 
of prokaryotes, seems not to be present in mitochondrial mRNAs. While sites in the 5’-leaders 
complementary to the 3’-end of the 15S rRNA have been noted (Li et al., 1982), their 
positions vary between -8 and -107 relative to the initiator AUG codon. Furthermore, in the 
case of cytochrome b (COB) deletion of the sequence motif complementary to the 3’-end of 
the 15S rRNA did not cause any changes in COB expression (Mittelmeier and Dieckmann, 
1995). Green-Willms et al. (1998) have shown that defined mutations of the 5’-mRNA leader 
of COX2 and COX3 can be suppressed by alterations of mRNA-specific activators and by 
mutations of mitochondrial ribosomal proteins. These components of the small ribosomal 
subunit, namely Mrp21p and Mrp51p, cause a suppression which is specific for certain COX2 
and COX3 alleles. Therefore the authors assume that yeast mitochondrial ribosomes play an 
active role in the recognition of the translational initiation signal. Since the suppression 
concerns both alleles of COX2 and COX3, it is not gene specific and may indicate that 
ribosomes re-cognise regions in the 5’-leaders of different mRNAs. Possibly there is a 
Introduction 
   13 
common sequence motif which is contained in all mitochondrial mRNA leader sequences. 
The octanucleotide sequence UAUAAAUA found in the leader regions of yeast 
mitochondrial mRNAs could represent this motif (Dunstan et al., 1997). This sequence is 
complementary to several regions of the mitochondrial 15S rRNA and might be involved in 
the mRNA-rRNA basepairing. Proteins like Mrp21p and Mrp51p could be involved in such 
an mRNA-rRNA interaction (Green-Willms et al., 1998). Since the octanucleotide sequence 
is not at a fixed position relative to the translational start and the complementary sequence is 
not found at the 3’-end of the rRNA, this interaction is not comparable to the Shine-Dalgarno 
mechanism (Shine and Dalgarno, 1974; Ringquist et al., 1992). Alternatively mitochondrial 
ribosomes could directly interact with mRNAs under participation of Mrp21p and Mrp51p 
(Green-Willms et al., 1998). The unusual feature of the yeast mitochondrial translation 
system that nuclearly encoded mRNA-specific translational activators exist could also point 
to an unknown mechanism of translation initiation. 
1.2.2.1  Specific translational factors 
The mitochondrial translation of at least five of the eight major mRNAs requires the action of 
one or more nuclear encoded gene-specific activator proteins (Table 2). These activator 
proteins are thought to recognise sites in the 5’-UTR of the mRNA (Jackson et al., 1990) and 
to interact with the mitoribosomal small subunit (Haffter et al., 1991). All translational 
activators are associated with the inner mitochondrial membrane (McMullin and Fox, 1993). 
Through these interactions the insertion of translation products into the appropriate 
respiratory complexes might be facilitated. 
 
Table 2: Factors involved in translation of specific yeast mitochondrial mRNAs 
mRNA Factor Localisation Ribosomal 
interaction 
References 
COX1 Mss51p 
 
Pet309p 
associated with inner 
membrane 
inner membrane 
n.d. Siep et al., 2000 
Decoster et al., 1990 
Manthey and McEwen, 1995 
COX2 Pet111p inner membrane n.d. Poutre and Fox, 1987 
COX3 Pet54p 
 
Pet122p 
 
Pet494p 
associated with inner 
membrane 
inner membrane 
 
inner membrane 
n.d. 
 
yes 
 
n.d. 
Costanzo et al., 1986 
 
Kloeckener-Gruissem et al., 
1988 
Müller et al., 1984 
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COB Cbs1p 
Cbs2p 
 
Cbp6p 
inner membrane 
associated with inner 
membrane 
n.d. 
n.d. 
yes 
 
n.d. 
Rödel, 1986a 
Rödel et al., 1986b 
 
Dieckmann and Tzagoloff, 
1985 
ATP9 Aep1p 
Aep2p 
n.d. 
n.d. 
n.d. 
n.d. 
Payne et al., 1993 
Finnegan et al., 1991 
 
Three nuclear genes, PET494, PET54 and PET122, are specifically required for COX3 
mRNA translation. Mutations in each of these genes abolish translation of a chimeric mRNA 
bearing the COX3 5’-UTR and the coding sequence of COB, showing that all three products 
act within the COX3 5’-UTR (Costanzo and Fox, 1988). Mutation of the translation initiation 
codon AUG to AUA had no effect on the levels of Cox3p, showing that the site of interaction 
is specified by other sequence or structural features (Folley and Fox, 1991). Deletion of the 
entire 5’-UTR completely prevented translation. Pet494p, Pet54p and Pet122p probably work 
together to carry out a similiar function. Using a GAL4-based two-hybrid system physical 
interactions have been detected between Pet54p and Pet122p, and between Pet54p and 
Pet494p (Brown et al., 1994). Genetic analysis of pet54 mutants also revealed functional 
interactions between Pet54p and Pet122p. Localization studies showed that Pet122p and 
Pet494p are integral inner membrane proteins, while half of the Pet54p is associated with the 
inner membrane and the other half is in soluble form (McMullin and Fox, 1993). Besides 
making contact with COX3 mRNA and the mitochondrial membrane, the Pet494p/54p/122p 
complex is likely to interact with the mitochondrial ribosome. Mutations of PET123, MRP1 
and MRP17 were identified to partially compensate for the loss of the C-terminus of Pet122p 
(McMullin et al., 1990; Hafter et al., 1990, 1991; Hafter and Fox, 1992). All three genes 
encode proteins of the small mitoribosomal subunit. These findings indicate that Pet122p 
promotes translation initiation of COX3 mRNA through an interaction with the small subunit 
of the mitoribosome. Taken together, all data point to a complex formed by the activators that 
mediates the interaction of the COX3 mRNA with the mitoribosome at the surface of the inner 
membrane. 
A similar picture arises for Cbs1p and Cbs2p, two proteins required for translation of COB 
mRNA (Rödel, 1986a). The respiratory deficiency due to mutations in the genes CBS1 and 
CBS2 can be suppressed by mitochondrial mutations replacing the COB leader by the 
untranslated leader of the ATP9 gene (Rödel et al., 1986b). Analysis of deletions in the 5’-
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UTR of COB mRNA mapped the site of action of the translational activators either between   
–170 and –104 or between –60 and the AUG at +1 (Mittelmeier and Dieckmann, 1995). 
Cbs1p behaves as an integral inner membrane protein, while Cbs2p behaves as a soluble 
protein which is associated with the inner membrane via ionic interactions (Michaelis et al., 
1991). A two-dimensional separation of small mitoribosomal subunit proteins indicated an 
association of Cbs2p with mitochondrial ribosomes (Michaelis et al., 1991) which was 
confirmed by coimmunoprecipitation of Cbs2p with the mitoribosomal protein Nam9p 
(Tzschoppe, 2001). 
Translation of COX2 mRNA is dependent on Pet111p (Poutre and Fox, 1987). Similar 
to other translational activators, Pet111p acts via the 5’-UTR of the mRNA. Studies with 
chimeric mRNA bearing the COX3 5’-UTR and the coding sequence of COX2 showed that 
Pet111p acts specifically at a site in the 54 nucleotides long COX2 5’-leader (Mulero and Fox, 
1993a). A translational defect resulting from a point mutation generated in the 5’-UTR of 
COX2 mRNA could be suppressed by a missense mutation in the PET111 gene (Mulero and 
Fox, 1993b). Further mutational analysis revealed functional elements as well as a possible 
stem loop structure at –20 to –35 in the 5’-untranslated region of COX2 mRNA (Dunstan et 
al., 1997). Like Pet122p and Pet494p, Pet111p has been detected in mitochondria as a tightly 
bound inner membrane protein (Strick and Fox, 1987). So far no functional link between 
Pet111p and the mitochondrial ribosome has been demonstrated. 
1.3 Isocitrate dehydrogenase 
An additional protein that binds specifically and with high affinity to the 5’-untranslated 
leaders of all major yeast mitochondrial mRNAs has been identified by mobility shift assays 
with mitochondrial extracts (Papadopoulou et al., 1990; Dekker et al., 1992). On SDS-PAGE 
this protein behaved as a doublet with an approximate size of 40 kDa (p40). Peptide sequence 
analysis identified p40 as the Krebs cycle enzyme (NAD+)-dependent isocitrate 
dehydrogenase (Idhp) (Elzinga et al., 1993). Idhp is present in all eukaryotic cells and 
catalyses a rate-limiting step in the Krebs cycle, namely the conversion of isocitrate to          
α-ketoglutarate coupled to the production of NADH. It is an allosterically regulated enzyme 
that in S. cerevisiae functions as an octamer composed of two nonidentical subunits, termed 
Idh1p (Mr 40 kDa) and Idh2p (Mr 39 kDa) (Keys and McAlister-Henn, 1990; Cupp and 
McAlister-Henn, 1991, 1992). Both enzyme and RNA-binding activities are specifically lost 
in cells containing disruptions in either IDH1 or IDH2, the nuclear genes encoding the two 
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subunits of the enzyme (Elzinga et al., 1993), thus demonstrating that both activities are 
dependent on the simultaneous presence of both subunits. Furthermore mutants that result in 
the loss of one or both Idhp subunits are unable to grow on the non-fermentable carbon source 
acetate, a phenotype shared with other Krebs cycle mutants, and grow very poorly on the non-
fermentable carbon source glycerol (Cupp and McAlister-Henn, 1992). The contribution of 
each subunit to regulation and catalysis was determined by mutation of a conserved serine 
residue at the proposed active site of each subunit (Cupp and McAlister-Henn, 1993). An 
S98A replacement in Idh2p resulted in a 60-fold decrease in Vmax, but had no effect on 
cooperativity with respect to isocitrate or AMP, whereas an S92A replacement in Idh1p 
resulted in a 6-fold decrease in Vmax, with complete loss of activation by AMP and a 2-fold 
decrease in cooperativity. Therefore a primary role for Idh2p in catalysis and for Idh1p in 
regulating the catalytic properties of Idh2p was suggested. Mutant proteins with affected 
enzymatic activity (Idh1pS92A, Idh2pS98A) have RNA-binding activity (Elzinga et al., 1993), 
while the mutant protein that affects RNA-binding activity (Idh1pK182L/Y184N) has normal 
enzymatic activity (Siep, 2001). 
Idhp is just one of a rapidly growing family of bifunctional RNA-binding proteins. Although 
it is an NAD+-binding protein containing a (di)nucleotide binding domain, RNA-binding 
could not be inhibited by (di-)nucleotides, suggesting that a region distinct from the 
Rossmann fold is involved in binding RNA (Siep, 2001). As the substrate isocitrate also did 
not inhibit RNA-binding the active site of the enzyme is not involved in RNA-binding (Siep, 
2001). RNA-binding could, however, be involved in regulation of the enzyme: addition of 
COX2 leader RNA inhibits the enzymatic activity of Idhp (Anderson et al., 2000) indicating a 
regulatory mechanism to switch between the RNA-binding and the enzymatic function. This 
mRNA is a potent steric inhibitor of Idhp enzymatic activity and this inhibition is relieved by 
the presence of the allosteric activator AMP. Therefore the mitochondrial AMP level could 
also be responsible for the switch between the two Idhp functions (Anderson et al., 2000). 
The binding region of Idhp is still unknown, but based on sequence comparison 
between K. lactis Idh1p and S. cerevisiae Idh1p a region potentially involved in RNA-binding 
(amino acids 170 to 190) was identified (Siep, 2001). From a 3D-structure based on E. coli 
NADP+-Idhp (Thorsness and Koshland, 1987), a cleft region dividing the subunit in a large 
and a small domain was identified. Three aromatic residues of the potential RNA-binding 
region (K182, K183, Y184) were notably sticking in the cleft. A mutant protein in which 
lysine 182 is changed to leucine and tyrosine 184 to asparagine (Idh1pK182L/Y184N) showed 
strongly reduced RNA-binding capacity and normal enzymatic activity (Siep, 2001). Since 
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Idhp of S. pombe is able to bind RNA with an affinity comparable to S. cerevisiae Idhp 
(Elzinga, 2000) although Idh1p contains a leucine at position 182 and an asparagine at 
position 184, it is unlikely that the mutated residues are directly involved in RNA-binding and 
suggest that other determinants are likely to play a role. 
Concerning the protein-RNA interactions it is also important to consider the sequence and the 
3D-structure of the respective RNA. RNA is a dynamic molecule with the ability to fold back 
through base pairing of complementary stretches to form secondary structures such as 
hairpins, bulges and internal loops. Interestingly, the possible stem loop at –20 to –35 of the 
COX2 mRNA which is bound by Idhp (Dekker et al., 1992) contains the sequence UCUAA, a 
motif that is conserved in a number of mitochondrial yeast mRNAs 18 to 37 bases upstream 
of the initiation codon. Mutational analysis reveals this region as a good candidate site for 
Pet111p action (Mulero and Fox, 1993b). Therefore, binding of Idhp and Pet111p could be 
mutually exclusive so that translation could be prevented until Idhp is replaced by Pet111p 
and/or other components of an initiation complex causing the mRNAs to be tethered to the 
inner membrane. 
The idea that Idhp is acting as a translational suppressor is supported by protein labelling 
experiments with strains lacking one of the Idhp subunits (de Jong et al., 2000). The absence 
of Idhp resulted in an increase of translational activity in isolated mitochondria. However, 
these newly produced proteins are degraded more rapidly resulting in a lowered steady-state 
level of respiratory chain proteins. The increased turnover observed in Idhp-deficient cells is 
consistent with the observation that mRNAs for Cox2p and Cox3p are prevented from 
membrane-tethering/-docking by a replacement of their 5’-UTR through the VAR1 5’-UTR 
(Sanchirico et al., 1998). The synthesis of Var1p, a protein of the mitoribosomal small 
subunit, should not be dependent on cotranslational membrane insertion. Indeed, the 
incorporation of Cox2p and Cox3p which were efficiently translated from the chimeric 
mRNAs was found to be severely defective (Sanchirico et al., 1998). In addition, the 
increased production of some membrane localised respiratory chain subunits and their 
subsequent increased degradation presumably triggers the induction of suppressor mutations. 
Gadde and McCammon (1997) made the interesting observation that yeast strains with Idh2p 
nonsense or null mutants initially grow very poorly on glycerol but accumulate extragenic 
mutations, termed glycerol suppressors, that enhance growth on this nonfermentable carbon 
source. Missense, nonsense and null mutations at the CIT1 locus encoding mitochondrial 
citrate synthase were the most common suppressors identified. In addition to CIT1, 3 other 
Krebs cycle enzyme genes are capable of suppressing idh2 mutations (Przybyla-Zawislak et 
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al., 1999). Genetic evidence shows that glycerol suppressor mutations only occur in Idhp 
deficient mutants, indicating that Idhp plays a unique role in S. cerevisiae growing on 
glycerol. Mutations in other Krebs cycle enzymes do not give rise to suppressor mutations 
which indicates that it is not a defective Krebs cycle which leads to these mutations 
(Przybyla-Zawislak et al., 1999). Thus, it is more likely that instead of a defective enzymatic 
function a defective RNA-binding function of Idhp gives rise to suppressor mutations. 
Possibly these suppressor mutations can compensate for the absence of the Idhp RNA-binding 
function. Therefore other Krebs cycle enzymes should be examined for RNA-binding affinity. 
Materials and Methods 
   19 
2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Instruments 
Bio-Imaging Analyzer BAS-1800 II FUJIFILM 
Chart Recorder 1327 BIO-RAD 
Dounce homogeniser BRAUN 
Econo Gradient Monitor BIO-RAD 
Econo Pump BIO-RAD 
Econo UV Monitor BIO-RAD 
Eraser RAYTEST 
Fluor-STM MultiImager BIO-RAD 
Fraction Collector 2110 BIO-RAD 
LI-COR DNA sequencer (model 4000/4200;) MWG-BIOTECH 
Rainbow Scanner SLT LABINSTRUMENTS 
Sonoplus BANDELIN ELECTRONIC 
2.1.2 Materials 
Acetyl-CoA ICN 
Acrylamide/Bisacrylamide ROTH, ICN 
AMP ICN 
ATP ICN 
Blue Sepharose CL-6B AMERSHAM PHARMACIA BIOTECH 
calf liver RNA Type IV SIGMA 
Centricon  YM-10 MILLIPORE 
Coomassie  Brilliant blue G250 MERCK 
Collodion Bags SARTORIUS 
Citric Acid ICN 
Dithiothreitol SIGMA 
dNTP’s INVITROGEN 
DTNB ICN 
ECLplus-SystemTM AMERSHAM PHARMACIA BIOTECH 
Gel Blotting Paper SCHLEICHER & SCHUELL 
Heparin Sepharose CL-6B AMERSHAM PHARMACIA BIOTECH 
Imaging plate BAS-IP MS 2325 FUJIFILM 
Imidazole MERCK 
ImmobilonTM-P PVDF-Membrane MILLIPORE 
Malic acid ICN 
NAD ICN 
NADH ICN 
Ni-NTA Agarose QIAGEN 
Oxalacetic acid ICN 
PMSF SIGMA 
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Precision Protein StandardsTM BIO-RAD 
Primers MWG-BIOTECH 
5´ IRD800-labelled primers MWG-BIOTECH 
Pwo-Polymerase BOEHRINGER MANNHEIM 
Restriction enzymes INVITROGEN 
T4-DNA-Ligase PROMEGA 
TEMED INVITROGEN 
Tissue Culture Test Plates 96flat/F TPP 
t RNA SIGMA 
Trans-labelTM ICN 
Tween 20 VWR-INTERNATIONAL 
[α-32P]-UTP ICN, AMERSHAM PHARMACIA BIOTECH 
X-ray films AMERSHAM PHARMACIA BIOTECH 
Zymolyase 20T ICN 
2.1.3 Kits  
Jetquick PCR Purification Spin Kit GENOMED 
Jetquick Gel Extraction Spin Kit GENOMED 
Jetquick Plasmid Miniprep Spin Kit GENOMED 
Protein Assay BIO-RAD 
Riboprobe  Combination System-SP6/T7 PROMEGA 
Thermo-Sequenase fluorescent labeled primer  
cycle sequencing kit with 7-deaza-dGTP 
AMERSHAM PHARMACIA BIOTECH 
2.1.4 Antibodies 
 Dilution in 1 x TBS-T with 5 % (w/v) 
skimmed milk powder  
Mouse-Anti-Cox3p (MOLECULAR PROBES) 1:1000 
Mouse-Anti-HA (BOEHRINGER 
MANNHEIM) 
1:1000 
Rabbit-Anti-Aac1p* 1:1000 
Rabbit-Anti-Idhp* 1:1000 
Sheep-Anti-mouse IgG-HRP (AMERSHAM 
PHARMACIA BIOTECH) 
1:5000 
Donkey-Anti-rabbit IgG-HRP (AMERSHAM 
PHARMACIA BIOTECH) 
1:5000 
 
Antibodies marked with (*) were kindly provided by H. van der Spek, Amsterdam. 
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2.1.5 Strains 
2.1.5.1  Escherichia coli (E. coli) 
Strain Genotype  Reference 
 
DH5α 
 
Φ80dlacZ∆M15, recA1, endA1, gyrA96, thi-
1, hsdR17  
(rK-, mK+), supE44, relA1, deoR, (lacZYA-
argF)U169 
 
 
Hanahan, 1983 
2.1.5.2  Saccharomyces cerevisiae (S. cerevisiae) 
Strain Genotype  Reference 
 
MMYO11 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1 
 
 
McCammon et al., 1990 
 
I2∆HL 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1, idh2::HIS3 
 
 
Przybyla-Zawislak et al., 
1999 
 
∆IDH1L 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1, idh1::LEU2 
 
 
Przybyla-Zawislak et al., 
1999 
 
I2∆CIT1L 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1, idh2::HIS3, 
cit1::LEU2 
 
 
Przybyla-Zawislak et al., 
1999 
 
I2∆MDH1L 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1, , 
idh2::HIS3, mdh1::URA3 
 
 
Przybyla-Zawislak et al., 
1999 
 
CIT1L 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1, cit1::LEU2 
 
 
Przybyla-Zawislak et al., 
1999 
 
MDH1L 
 
MATα, ade2-1, can1-100, his3-11, his3-15, 
leu2-3, leu2-112, trp1-1, ura3-1, 
mdh1::URA3 
 
 
Przybyla-Zawislak et al., 
1999 
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Y05376 
 
MATa, his3∆1, leu2∆0, met15∆0, ura3∆0, 
cit1::kanMX4 
 
 
EUROSCARF 
 
Y04934 
 
MATa, his3∆1, leu2∆0, met15∆0, ura3∆0, 
mdh1::kanMX4 
 
 
EUROSCARF 
2.1.6 Media 
2.1.6.1  E. coli-media 
LB 1.0 % (w/v) Tryptone 
 0.5 % (w/v) Yeast extract 
 0.5 % (w/v) NaCl 
 2.0 % (w/v) Agar (for LB-Plates) 
  
Marker selection 
 
100 µg/ml Ampicillin 
 
2.1.6.2  S. cerevisiae-media 
YPAce 1.0 % (w/v) Yeast extract 
 2.0 % (w/v) Peptone 
 2.0 % (w/v) Potassium phosphate 
 0.003 % (w/v) Adenine sulphate; pH6.0 
 2.0 % (w/v) Agar (for YP-Plates) 
  
YPD 1.0 % (w/v) Yeast extract 
 2.0 % (w/v) Peptone 
 2.0 % (w/v) Glucose 
 2.0 % (w/v) Agar (for YP-Plates) 
  
YPGal 1.0 % (w/v) Yeast extract 
 2.0 % (w/v) Peptone 
 2.0 % (w/v) Galactose 
 2.0 % (w/v) Agar (forYP-Plates) 
  
YPGly 1.0 % (w/v) Yeast extract 
 2.0 % (w/v) Peptone 
 2.0 % (v/v) Glycerol 
 2.0 % (w/v) Agar (for YP-Plates) 
  
WO 1.7 g/l Yeast nitrogen base 
 5.0 g/l Ammonium sulphate 
 2.0 % (w/v) Glucose 
 2.0 % (w/v) Agar (for WO-Plates) 
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2.1.6.3  Buffers 
TBE 90 mM Tris 
 90 mM Boric acid 
 2.5 mM EDTA 
  
TBS 137 mM NaCl 
 20 mM Tris-HCl (pH 7.4) 
  
TBS-T 1 x TBS  
 0.1 % (v/v) Tween 20 
  
PBS 140 mM NaCl 
 2.7 mM KCl 
 10.1 mM Na2HPO4 
 1.8 mM KH2PO4 
  
2.1.6.4  Solutions for Bradford assay 
Bradford solution 0.01 % (w/v) Coomassie  Brilliant blue 
G250 
5 % (v/v) Ethanol 
10 % (v/v) H3PO4 
2.1.6.5  Solutions for SDS-PAGE 
Running gel (12.5 %) 375 mM Tris-HCl, pH 8.8 
 12.5 % (w/v) Acrylamide 
 0.33 % (w/v) Bisacrylamide 
 0.1 % (w/v) SDS 
 0.1 % (w/v) Ammonium persulfate 
 0.1 % (v/v) TEMED 
  
Stacking gel 125 mM Tris-HCl, pH 6.8 
 4 % (w/v) Acrylamide 
 0.1 % (w/v) Bisacrylamide 
 0.1 % (w/v) SDS 
 0.1 % (w/v) Ammonium persulfate 
 0.1 % (v/v) TEMED 
  
Running buffer 25 mM Tris 
 192 mM Glycine 
 0.1 % (w/v) SDS 
  
6 x loading buffer 300 mM Tris-HCl, pH 6.8 
 30 % (w/v) Glycerol 
 10 % (w/v) SDS 
 0.1 % (w/v) Bromphenol blue 
 600 mM DTT or 5 % ß-mercaptoethanol 
(freshly added) 
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Coomassie blue staining 42 % (v/v) Methanol 
 17 % (v/v) Acetic acid 
 0.1 % (w/v) Coomassie  Brilliant blue 
G250 
  
Destaining solution 30 % (v/v) Methanol 
 7 % (v/v) Acetic acid 
 
2.1.6.6  Solutions for silver staining 
Fixation 50 % (v/v) Ethanol 
5 % (v/v) Acetic acid 
 
Washing 50 % (v/v) Methanol 
 
Sensitizer 0.02 % (w/v) Sodium thiosulfate 
 
Staining solution 0.1 % (w/v) AgNO3 
 
Developer 0.04 % (v/v) Formaldehyde 
2 % (w/v) Na2CO3 
 
Stop solution 5 % (v/v) Acetic acid 
 
2.1.6.7  Solutions for Western blot 
Transfer buffer 192 mM Glycine 
 25 mM Tris  
 5.0 % (v/v) Methanol 
 0.1 % (w/v) SDS 
  
Ponceau S staining 0.5 % (w/v) Ponceau S 
 1 % (v/v) Acetic acid 
  
Blocking solution 1 x TBS-T 
 5 % (w/v) skimmed milk powder 
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2.1.6.8  Solutions for band shift assay 
Non-denaturing polyacrylamide gel (4 %) 4 % (w/v) Acrylamide 
 0.21 % (w/v) Bisacrylamide 
 1 x TBE 
 0.06 % (w/v) Ammonium persulfate 
 0.25 % (v/v) TEMED 
  
Layermix 0.1 % (w/v) Bromphenolblue 
 10 % (v/v) Glycerol 
  
10 x Binding buffer 100 mM Tris-HCl, pH 7.5 
 1 mM EDTA 
 30 mM MgCl2 
 500 mM NaCl 
 50 % (v/v) Glycerol 
 70 mM ß-mercaptoethanol 
 8 mM PMSF 
  
 
2.1.7 Vectors 
Vector Genetic marker Reference 
pGH1 Ampr, URA3, CEN-ARS, TEF-promoter, 
MCS, GFP-ORF, HA-Epitope 
 
Mumberg et al., 1995; 
Kruckeberg et al., 1999 
pGH2 Ampr, URA3, 2 µ, TEF-promoter, MCS, 
GFP-ORF, HA-Epitope 
 
Mumberg et al., 1995; 
Kruckeberg et al., 1999 
pGH7 Ampr, LEU2, CEN-ARS, TEF-promoter, 
MCS, GFP-ORF, HA-Epitope 
 
Mumberg et al., 1995; 
Kruckeberg et al., 1999 
pGH8 Ampr, LEU2, 2 µ, TEF-promoter, MCS, 
GFP-ORF, HA-Epitope 
 
Mumberg et al., 1995; 
Kruckeberg et al., 1999 
YCplac33 
 
Ampr, URA3, CEN-ARS, lacZ’ Gietz and Sugino, 1988 
 
Table 3. Vectors used for the plasmids construction. 
The pGH1/2 vectors are modified versions of p41/42 TEF (Mumberg et al., 1995) containing 
GFP (derived from the plasmid pGFP1 (Kruckeberg et al., 1999)) and the HA-Epitope. The 
pGH7/8 vectors are similiar modified versions of p415/p425TEF. 
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2.1.8 Recombinant plasmids 
Plasmid Insert Reference 
pCOX2∆9 
 
 
ORF coding for 5`-UTR and coding region 
of COX2(-54 to +756) 
Papadopoulou et al., 1990 
pCOBHE 
 
ORF coding for 5`-UTR of COB(-243 to -
26) 
 
Dekker et al., 1992 
Yep352-
Idh1pS92A 
ORF coding for Idh1p(S92A) 
 
 
Cupp and McAlister-Henn, 
1993 
Yep352- 
Idh1pK182L; Y184N 
ORF coding for Idh1p(K182L, Y184N) 
 
 
Siep, 2001 
2.1.9 Primers 
Primer Sequence (5‘ → 3‘) Enzyme 
site 
1 GGGGTTAATTAATGTCAGCGATATTATCAACAAC PacI 
2 CCCGGCGGCCGCCGGCGCGCCGTTCTTACTTTCGATT
TTCTTTAC 
NotI, AscI 
3 GGGGTTAATTAATGTTGTCAAGAGTAGCTAAACG PacI 
4 CCCGGCGGCCGCCGGCGCGCCTTTACTAGCAACAAAG
TTGACACC 
NotI, AscI 
5 CGCGCCGGCGGCCGCTCATCATCATCATCATCATTAA
GG 
NotI 
6 CGCGCCTTAATGATGATGATGATGATGAGCGGCCGC
CGG 
NotI 
uni-21* TGTAAAACGACGGCCAGT  
rev-29* CAGGAAACAGCTATGACC  
 
Table 4. Primers used for the plasmids construction and for sequencing.  
The enzyme recognition sites are indicated in italic. The primer annealing regions are in bold, 
(*) indicates 5’ IRD800 labelled sequencing primers. 
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2.1.10 Recombinant plasmids of these work 
Plasmid Primers Template Protein 
pGH1-Cit1p-GFP-HA 1, 2 yeast cDNA Cit1p 
pGH1-Cit1p-HA  pGH1-Cit1p-GFP -HA Cit1p 
pGH1-Cit1p-His6 5, 6 pGH1-Cit1p-HA Cit1p 
pGH7-Mdh1p-GFP-HA 3, 4 yeast cDNA Mdh1p 
pGH7-Mdh1p-HA  pGH7-Mdh1p-GFP-HA Mdh1p 
pGH7-Mdh1p-His6 5, 6 pGH7-Mdh1p-HA Mdh1p 
YCplac33-Idh1pS92A  Yep352-Idh1pS92A Idh1pS92A 
YCplac33-Idh1pK182L; Y184N  Yep352- Idh1pK182L; Y184N  Idh1pK182L; Y184N 
 
Table 5. List of the plasmids constructed in this work. 
The name of the plasmids are indicated on the left and the resulting protein on the right. The 
primers and the template used in the PCR or in the further cloning strategy are indicated. 
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2.2 Methods 
2.2.1 Plasmids 
The oligonucleotide primers used for PCRs are listed in Table 2. The combination of primers 
and the created constructs are listed in Table 3. The annealing temperature (Ta) of the primers 
was calculated according to the following formula (MWG-BIOTECH): 
 
Ta = 69.4°C + 0.41 ∗  (% of Primer GC) – 650/Primer length 
 
The following reaction mixture was used: 
 
 Final concentration 
Template DNA 1 ng/µl 
Upstream primer (100 pmol/µl) 1 pmol/µl 
Downstream primer (100 pmol/µl) 1 pmol/µl 
dNTP mix (10 mM of each dNTP) 200µM of each dNTP  
PCR puffer (10 x) 1 x 
Pwo Polymerase (5 units/µl) 2 units 
Total volume 100 µl 
 
The following PCR program was used: 
 
General PCR 
5 min 95°C Initial denaturation 1 x 
45 sec 94°C 
45 sec Ta + 5°C 
1 min 72°C 
Denaturation 
Annealing 
Elongation 
5 x 
45 sec 94°C 
45 sec Ta 
2 min 72°C 
Denaturation 
Annealing 
Elongation 
25 x 
5 min 72°C Final elongation 1 x 
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Standard techniques were used for restriction endonuclease analysis of DNA, ligation of DNA 
fragments, transformations and recovery of plasmid DNA from E. coli (Sambrook et al., 
1989). Purification of PCR products and plasmids was carried out with the kits listed in 
section 2.1.3.  
A plasmid containing the active site mutant Idh1pS92A, in which the serine at position 92 is 
changed into an alanine was generously provided by Lee McAlister-Henn (Texas, USA). The 
mutant gene coding for Idh1pK182L; Y184N which is deficient in mitochondrial RNA- binding 
because of the substitution of the residues lysine at position 182 and tyrosine at position 184 
into leucine and asparagines was obtained from Sandra Elzinga (Amsterdam, Netherlands). 
Constructs YCplac33 Idh1pS92A and YCplac33 Idh1pK182L; Y184N were derived by subcloning 
the according XbaI fragments containing the complete coding region of IDH1 into YCplac33. 
Plasmids pGH1-Cit1p-GFP-HA and pGH7-Mdh1p-GFP-HA, in which the yeast genes are 
fused C-terminal to the GFP gene and the HA-epitope, were obtained by cloning PCR 
products into the pGH1 or the pGH7 vector. 
The vectors pGH1-Cit1p-HA and pGH7-Mdh1p-HA were constructed from the pGH1-Cit1p-
GFP-HA and pGH7-Mdh1p-GFP-HA vectors by removing the GFP gene with the enzyme 
AscI and religation of the resulting AscI digested plasmids. 
The constructs pGH1-Cit1p-HA and pGH7-Mdh1p-HA were used to tag CIT1 and MDH1 at 
their C-termini with 6 histidine residues. To create the C-terminal fusion the oligonucleotides 
no. 5 and 6 which are coding for 6 histidine residues including a stop signal and creating 
sticky ends of an AscI-site were annealed. The plasmids pGH1-Cit1p-His6 and pGH7-Mdh1p-
His6 were obtained by cloning of the annealing product into the AscI-site of the respective 
constructs. 
2.2.2 Sequencing 
DNA sequences were determined by the dideoxy chain termination method of Sanger (Sanger 
et al., 1977) using 5´ IRD800-labelled primers and the Thermo Sequenase fluorescent labelled 
primer cycle sequencing kit with 7-deaza-dGTP as described by the manufacturer and the   
LICOR DNA sequencer. Primers used for sequencing are listed in Table 2. The annealing 
temperature of the primers was calculated according the following formula (MWG-BIOTECH): 
 
Ta = 69.4°C + 0.41 ∗  (% of Primer GC) – 650/Primer length + 3°C 
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2.2.3 Transformation of yeast cells 
Yeast cells were transformed using the one-step procedure (Chen et al., 1992). 
2.2.4 Isolation of yeast mitochondria  
2.2.4.1  Large scale preparation of mitochondria (modified procedure of Grivell , 1971) 
Yeasts were grown to stationary phase in 3 l YPGal medium. Cells were harvested by 
centrifugation at 3000 x g for 5 minutes. After washing with water cells were resuspended in 
2 ml/g wet weight DTT buffer and incubated at 30°C for 20 min. Cells were washed with    
1.2 M sorbitol followed by suspension in 7 ml/g wet weight zymolyase buffer. The cells were 
incubated at 30°C with gentle shaking until spheroblasts were formed (about 30 min). 
Spheroblasts were then washed with 1.2 M sorbitol, suspended in 7 ml/g wet weight breaking 
buffer and lysed in a Dounce homogeniser. Unbroken cells and the cell debris were removed 
by centrifugation of the lysate at 3000 x g for 5 min at 4°C. Mitochondria were pelleted by 
centrifugation at 13000 x g for 30 min at 4°C, suspended in a small volume of SEM buffer 
and stored at -70°C. 
 
DTT buffer 100 mM TrisSo4, pH9.4 
 10 mM DTT 
  
Zymolyase buffer 1.2 M Sorbitol 
 20 mM Potassium phosphate buffer, pH 7.4 
 2 mg/g wet weight Zymolyase 20T 
  
Breaking buffer 0.6 M Sorbitol 
 10 mM Tris-HCl, pH 7.4 
 1 mM EDTA 
 0.2 % BSA (fatty acid free) 
 1 mM PMSF (freshly added) 
  
SEM buffer 250 mM Saccharose 
 1 mM EDTA 
 10 mM MOPS, pH7.2 with KOH 
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2.2.4.2  Preparation of mitochondria (modified procedure of McKee, 1984) 
The harvested and washed cells of 500 ml cultures were incubated in DTT buffer (5 ml/g wet 
weight) at 30°C for 20 min, washed with water and treated with zymolyase in spheroblast 
buffer (2 ml/g wet weight). After washing the spheroblasts were suspended in pottering buffer 
(2.5 ml/g wet weight) and lysed by using a Dounce homogeniser. Cell debris were removed 
by centrifugation at 3000 x g for 3 min at 4°C. The mitochondria were then pelleted, 
resuspended in SEM buffer and stored at -70°C. 
 
DTT buffer 100 mM Tris, pH9.0 
 2.5 mM DTT 
  
Spheroblast buffer 1.35 M Sorbitol 
 100 mM EDTA, pH 7.4 
 1 mg/g wet weight Zymolyase 20T 
  
Pottering buffer 0.6 M Mannitol 
 1 mM EDTA, pH 6.7 
  
2.2.5 Purification of mitochondrial proteins 
For the preparation of mitochondrial extracts, frozen mitochondria from large scale 
preparations were thawed, pelleted, suspended in 10 ml of column buffer and broken by 
sonication for 4 x 15 sec. The lysate was applied to a Blue Sepharose column which had been 
equilibrated with column buffer. Proteins were eluted using a step gradient of 100-200-      
500 mM KCl in column buffer. Fractions were dialysed over night against dialysis buffer and 
concentrated by using Centricon  YM-10. The 0.2 M KCl Blue Sepharose protein fraction 
containing the RNA-binding factor(s) was adapted for about 1 hour to 50 mM KCl and then 
incubated 1 hour at 4°C with Heparin Sepharose equilibrated with column buffer. The 
Heparin Sepharose was pelleted by centrifugation 5 min at 500 x g and washed with column 
buffer. Proteins were eluted using a step gradient of 100-200-300-500 mM KCl in column 
buffer. The fractions were dialysed 4 hours at 4°C against dialysis buffer and assayed for 
RNA- binding activity. Proteins were analysed by SDS-PAGE and silver staining. 
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Column buffer 50 mM KCl 
 20 mM Tris, pH 7.5 
 0.1 mM EDTA 
 10 % Glycerol 
 1 mM PMSF 
 6 mM ß-mercaptoethanol 
  
Dialysis buffer 20 mM KCl 
 20 mM Tris, pH 7.5 
 0.1 mM EDTA 
 10 % Glycerol 
 1 mM PMSF 
 6 mM ß-mercaptoethanol 
  
2.2.6 Affinity purification of recombinant mitochondrial proteins 
Yeast null mutant strains transformed with the plasmid pGH1-Cit1-6xHis or pGH7-Mdh1-
6xHis carrying the coding region for the genes of interest and a His-Tag were inoculated from 
an overnight selection culture and grown at 30°C in YPGal medium. Mitochondria were 
prepared, suspended in buffer A and lysed by sonication for 4 x 15 sec. The lysate was 
incubated with Ni-NTA agarose which had been equilibrated with buffer A. The Ni-NTA 
agarose was pelleted by centrifugation 5 min at 500 x g and washed with buffer A. Proteins 
were eluted using imidazole as competitor in buffer B, assayed for enzymatic and RNA- 
binding activity and stored at – 70°C. The purification grade was analysed by SDS-PAGE and 
silver staining. 
 
buffer A 20 mM Imidazol 
 300 mM NaCl 
 50 mM NaH2PO4, pH 7.4 
 0.1 mM EDTA 
 10 % Glycerol 
 1 mM PMSF 
 6 mM ß-mercaptoethanol 
  
buffer B 200 mM Imidazol 
 300 mM NaCl 
 50 mM NaH2PO4, pH 7.4 
 0.1 mM EDTA 
 10 % Glycerol 
 1 mM PMSF 
 6 mM ß-mercaptoethanol 
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2.2.7 Determination of Citrate synthase activity (Srere et al., 1963) 
Citrate synthase activity was measured in 1 ml 100 mM Tris-HCl buffer, pH 8.1, 0.1 mM 
DTNB (Ellman´s reagent), 0.3 mM acetyl-CoA and 0.5 mM oxalacetic acid. Assays were 
performed at room temperature and initiated by the addition of oxalacetic acid. The reaction 
was follwed spectrophotometrically at 412 nm controlling a possible acetyl-CoA deacylase 
activity and after the addition of oxalacetic acid measuring the increase in absorbance 
resulting from the formed mercaptide ion (acetyl-CoA + oxalacetic acid → citrate + CoASH; 
CoASH + DTNB → CoA-TNB + TNB-). One unit forms one micromole of CoASH per 
minute under the described conditions. Specific activity is expressed as enzyme unit(s) per 
milligram of protein. 
 
The enzymatic activity was calculated according to the following formula: 
 
d(DTNB)ε
/minΔAUnits
412
412
∗
=  
 
The specific enzymatic activity was calculated according to the following formula: 
 
mixturereactionenzyme/mlmgd(DTNB)ε
/minΔAUnits/mg
412
412
∗∗
=  
 
ε412 (DTNB) = 13.6 mM-1 cm-1 
d = 1 cm 
 
2.2.8 Determination of Malate dehydrogenase activity (McAlister-Henn and 
Thompson, 1987) 
Malate dehydrogenase activity was measured in 1 ml 50 mM potassium phosphate buffer, pH 
7.5, 0.12 mM NADH (freshly prepared) and 0.33 mM oxalacetic acid (freshly prepared). 
Assays were performed at room temperature and initiated by the addition of partial or total 
purified protein. The reaction was followed spectrophotometrically at 340 nm measuring the 
decrease in absorbance resulting from the oxidation of NADH. One unit oxidizes one 
micromole of NADH per minute under the described conditions. Specific activity is expressed 
as enzyme unit(s) per milligram of protein. 
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The enzymatic activity was calculated according to the following formula: 
 
d(NADH)ε
/minΔAUnits
340
340
∗
=  
 
The specific enzymatic activity was calculated according to the following formula: 
 
mixturereactionenzyme/mlmgd(NADH)ε
/minΔAUnits/mg
340
340
∗∗
=  
 
ε340 (NADH) = 6.22 mM-1 cm-1 
d = 1 cm 
2.2.9 In vitro transcription 
Templates for run-off in vitro transcription were produced by digestion of respective plasmids 
with suitable restriction endonucleases (schematically represented in Fig. 2). After 
purification of digested DNA, run-off transcripts of pCOX2∆9*RsaI, pCOX2∆9*HindIII and     
pCOBHE*EcoRI were made by incubation of 250 ng of template DNA for 90 min at 37°C in 
the presence (for direct binding studies) or absence (for competition assays) of [α-32P]-UTP 
according to standard procedures (Melton, 1984). T7 COX2 transcripts contain either the     
5’-leader (-54 to + 50) of COX2 or the 5’-leader of COX2 plus the corresponding coding 
region (-54 to +756) from S. cerevisiae. SP6 transcripts contain the 5’-leader of COB (-343 to 
-26) from S. cerevisiae. All three transcripts start with polylinker sequences derived from the 
corresponding transcription vector. Unincorporated nucleotides were removed by purification 
over a 1 ml Sephadex-G50 column. Yields of labelled transcripts were calculated from the 
incorporation of [α-32P]-UTP into RNA. Their integrity was analysed on 6 % polyacryl-
amide/7 M urea gels and visualised by autoradiography. 
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COX2
COX2
COB
-leader
-leader/gene
-leader
T7                                                    I                                                                      Size (nt)ATG Rsa
T7                                                                                                               IIIATG Hind
SP6                                                                            RIEco
30         11             54                    50
                                                                                                                                                              145
30         11             54                   709                                                                        33
 
                                                                                                                                                              837
27                        317                                              28
                                                                                                                                                              372  
 
Fig. 2: DNA templates used for in vitro transcription. 
Right-angled arrows denote the start and direction of transcription. Polylinker sequences 
(hatched lines); nucleotides upstream of the transcriptional start (white bars), leaders (lightly-
shaded boxes), initiation codon (ATG) and coding regions (black boxes) are indicated. 
Templates were linearised by cleavage at the restriction sites shown. 
2.2.10 In vitro RNA-protein binding assay 
The RNA-protein binding assay was performed according to the protocol developed for the 
analysis of NAD+-depending Isocitrate dehydrogenase to mitochondrial RNAs (Papadopoulou 
et al., 1990). 
For a standard experiment 1 µg of purified protein was mixed with 0.5 up to 3 ng [α-32P]-
UTP labelled RNA (100 cpm) in a final volume of 30 µl binding buffer and incubated for     
15 min at 30°C. Calf liver competitor RNA (1 µg) was added in the reaction mixture in order 
to minimise the non-specific association of proteins with RNA. For competition assays 
different amounts of molar excess of unlabelled RNA probes were preincubated with the 
protein for 5 min at 30 ° C prior to the addition of the specific labelled probe and further 
incubation for 15 min. After incubation, the protein-RNA complexes were resolved by 
electrophoresis through 4 % non-denaturing polyacrylamide gels run at 180 V for 2.5 hours at 
4°C using 1 x TBE as gel and running buffer. The gels were dried and visualised by 
autoradiography. 
 
Binding buffer 50 mM NaCl 
 10 mM Tris, pH 7.5 
 0.1 mM EDTA 
 5 % Glycerol 
 0.8 mM PMSF 
 7 mM ß-mercaptoethanol 
 3 mM MgCl2 
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2.2.11 In vitro translation 
For efficient translation, isolated mitochondria were resuspended in 0.6 M mannitol to a final 
concentration of 3 mg protein per ml and incubated in optimised protein synthesising medium 
in the presence of 8 µl/ml Trans-LabelTM at 30°C for 1 hour. 250 µl samples were taken at   
30 min and 60 min. An excess of cold methionine (0.2 M) was added to start the chase and 
samples were taken after 60 min. The samples were pelleted by centrifugation for 2 min at 
15000 x g, washed with 0.6 M mannitol/1 mM EDTA (pH 6.7), separated on a SDS-PAGE, 
blotted on a PVDF membrane and analysed by immunodetection. 
 
optimised protein synthesising medium 600 mM Mannitol 
 150 mM KCl 
 15 mM KH2PO4 
 12.5 mM MgSO4 
 4 mM ATP 
 0.5 mM GTP 
 5 mM α-Ketoglutarate 
 5 mM Phosphoenolpyruvate 
 10 units/ml Pyruvate kinase 
 0.1 mM amino acids (minus methionine) 
 20 mM Tris 
 3 mg/ml Bovine serum albumin, pH7.2 
  
2.2.12 Determination of the protein concentration 
The protein concentration was determined using the protein assay as described by the supplier 
or by Bradford (Bradford, 1976). 
2.2.13 Western blot analysis 
Proteins were separated on a 12.5 % polyacrylamide gel in the presence of SDS. Proteins 
were transferred to a PVDF membrane using the tank blotting method for 1 h at 4°C at        
1,5 mA/cm2. Membranes were blocked over night at 4°C or 1 hour at room temperature with 
5 % (w/v) non-fat dry milk in TBS-T. Membranes were probed with polyclonal or 
monoclonal antisera for 1 hour at room temperature and then washed three times for             
10 minutes in TBS-T. Horseradish peroxidase-conjugated anti-rabbit or anti-mouse antibodies 
were used as secondary antibodies. The secondary antibody was added to the membranes for 
30 minutes at room temperature and the membranes were again washed three times for         
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10 minutes in TBS-T. Antigen-antibody complexes were visualised by enhanced 
chemiluminescence (ECL plus). 
2.2.14 Blue native gel-electrophoresis 
The blue native gel-electrophoresis was performed as described by Schägger and Jagow 
(1991). Solubilisation of mitochondria was achieved by using 2 % lauryl-maltoside. 
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3 RESULTS 
3.1 Characterisation of Idh1 mutant proteins 
Idhp is a member of a still growing family of enzymes with an additional RNA-binding pro-
perty. To get more information about the mode of action of that bifunctional protein and to 
understand the link between dehydrogenase and RNA-binding activities an enzymatically 
deficient isocitrate binding site mutant, IDH1S92A (Cupp and McAlister-Henn, 1993), and a 
mutant deficient in RNA-binding, IDH1K182L/Y184N (Siep, 2001), were used. 
3.1.1 Complementation analysis of idh1 mutants 
A functional isocitrate binding site of Idh1p is necessary for respiratory growth. 
Mutant genes encoding Idh1pS92A and Idh1pK182L/Y184N were expressed under control of the 
authentic promoter in the single-copy vector YCplac33. Each of the proteins was expressed in 
the respiratory deficient ∆idh1 strain ∆IDH1L and the transformants were tested for their 
ability to restore normal growth on the non-fermentable carbon source glycerol. The wild type 
strain MMYO11 was used as a positive control. The idh1 null mutant strain and the idh1 null 
mutant strain transformed with the vector YCplac33 were used as negative controls. The 
mutant deficient in mitochondrial mRNA-binding did grow on glycerol while the enzymatic 
mutant Idh1pS92A did not (Fig. 3). This is  contrary to the observation that active site mutants 
of Idh1p are able to confer normal respiratory growth (Lin et al., 2001) and indicates that the 
enzymatic function of Idhp is required for growth on that non-fermentable carbon source. To 
test whether instability of Idh1pS92A is responsible for the idh1 null mutant phenotype the 
steady state concentration was analysed. 
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Fig. 3: Complementation behaviour of Idh1 mutant proteins in strain ∆IDH1L  
Strain ∆IDH1L was transformed with YCplac33 as a negative control or with plasmids 
encoding Idh1pS92A or Idh1pK182L/Y184. Strain MMYO11 served as a positive control. All 
strains were grown overnight in liquid minimal medium supplemented with selective amino 
acids and resuspended to 2 units OD600. This suspension was serially diluted in 10-fold steps. 
For each strain, 5 µl from each dilution were spotted onto rich medium with glycerol as a 
carbon source (YPGly). Growth of cultures on glycerol medium was monitored after 3 days 
of incubation at 30°C. 
3.1.2 Influence of idh1 mutations on protein stability 
The Idh1 mutant proteins show reduced steady state levels. 
In order to compare the stability of the wild type protein and the mutant proteins mitochondria 
of ∆IDH1L transformants expressing either Idh1pS92A or Idh1pK182L/Y184N were isolated. The 
wild type strain MMYO11 was used as a positive control. ∆IDH1L bearing or not bearing the 
vector YCplac33 was used as negative control. Equal amounts of mitochondrial proteins were 
separated on a 15 % SDS-PAGE, transferred to PVDF membrane and probed with a 
polyclonal Idh antibody. As the IDH1 genes are expressed from their own promoter their 
expression should be similiar. Fig. 4 shows that only the wild type strain (lane 1) contains 
equal amounts of the Idh subunits while the ∆IDH1L transformants expressing Idh1pS92A 
(lane 4) and Idh1pK182L/Y184N (lane 5) contain less Idh1p (upper band) and a wild type like 
amount of Idh2p (lower band). Other weak signals which were also detected in the controls 
probably result from crossreactions with the antibody. To consider the fact that Idhp is an 
abundant protein, comprising at least 0.4 % of total mitochondrial protein (Dekker et al., 
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1991), it could be ne-cessary to increase the expression level. Since Idh1pS92A and 
Idh1pK182L/Y184N expressed under control of the authentic promoter in multi-copy vectors also 
show reduced steady state levels (data not shown) the impaired function of Idh1p seems to be 
responsible for that behaviour. 
 
 
 
 
Fig. 4: Stability of Idh1 mutant proteins in strain ∆IDH1L 
Mitochondria were isolated from MMYO11 (1), strain ∆IDH1L (2) and strain ∆IDH1L 
transformed with the vector YCplac33 (3) or with plasmids encoding Idh1pS92A (4) or 
Idh1pK182L/Y184N (5). Western blot analysis was performed with a polyclonal antiserum 
directed against Idhp. 
3.1.3 Effect of idh1 mutations on mitochondrial translation products 
The absence of Idh1p leads to reduced steady state levels of Cox1p, Cox2p and Cox3p and of 
Cytb (de Jong et al., 2000). Since the effect is most pronounced with Cox3p the analysis of 
the influence of idh1 mutations on mitochondrially encoded proteins was focused on Cox3p. 
Mitochondria of the wild type, the idh1 null mutant and ∆IDH1L transformants expressing 
one of the idh1 mutant proteins were prepared for an in vitro translation assay. Equal amounts 
of mitochondria were incubated with protein synthesising medium containing L-[35S] labelled 
methionine as described in Materials and Methods (2.2.11). After 30 and 60 min the pulse-
labelled samples were taken. The labelling reaction was then stopped by addition of an excess 
of unlabelled methionine to follow the turnover of the synthesised proteins and the chase 
samples were taken after 60 min. After gel-electrophoresis and Western blotting the labelled 
proteins were visualised using a phosphorimager (Fig. 5A). Contrary to the expectations that 
the synthesis of Cox1p, 2 and 3 is strongly increased in the absence of Idh1p and that the 
increase of newly synthesised proteins in the idh1 null mutant is accompanied by an enhanced 
turnover (de Jong et al., 2000) the results presented in Fig. 5A show wild type like synthesis 
(Fig. 4A; lanes 30/60 min pulse of wt and ∆idh1) and turnover (Fig. 5A; lanes 60 min chase 
wt and ∆idh1). Similarly, increase in protein synthesis (Fig. 5A; lanes 30/60 min pulse of 
idh1S92A  and idh1K182L/Y184N) and enhanced turnover (Fig. 5A; lanes 60 min chase of idh1S92A  
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and idh1K182L/Y184N) cannot be observed in idh1 transformants. The mitochondrial translation 
activity of strains MMYO11 and ∆IDH1L was lower, perhaps because these strains are not 
isogenic. The effect of idh1 mutations on steady-state levels of cytochrome c oxidase were 
analysed with antisera directed against subunit Cox3p. Equal protein amounts in all lanes 
were monitored by using a polyclonal antibody for the ATP-ADP carrier Aac1p (Fig. 5B). 
The enzymatic mutant of Idh1p (panel c) shows decreased amounts of Cox3p and Cox3p 
instability like a null mutant (panel b). The RNA-binding deficient mutant (panel d) turned 
out to have wild type level (panel a) of Cox3p. 
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Fig. 5: Translation in mitochondria from idh1 mutants compared to wild type 
Mitochondria from MMYO11 (wt), strain ∆IDH1L (∆idh1) and strain ∆IDH1L transformed 
with plasmids encoding Idh1pS92A (idh1S92A) or Idh1pK182L/Y184N (idh1 K182L/Y184N) were 
isolated and used for a pulse-chase labelling experiment. Proteins were pulse-labelled with   
L-[35S] methionine for 30 and 60 min. After addition of a large excess of unlabelled 
methionine, mitochondria were chased for 60 min. Samples were taken at the indicated time 
points and resolved on 12.5 % SDS-PAGE. 
(A) After transfer to a PVDF membrane bands were visualised using a phosphorimager. 
Positions of the mitochondrial products are indicated on the right. 
(B) Cox3p was detected with a monoclonal antibody and as a control an antibody against 
Aac1p was used. Cox3p bands which are marked with asterisks indicate an enhanced 
turnover. 
3.2 Evidence for occurrence of Idhp in a high molecular weight complex 
Idhp is in a high molecular weight complex. 
On one hand it seems conceivable that Idhp as an important part of the Krebs cycle interacts 
with other enzymes to form a metabolon (Robinson et al., 1987). On the other hand Idhp is 
involved in the regulation of mitochondrial translation by binding to mRNAs and therefore 
might be connected with proteins of the mitochondrial translation machinery. 
To detect possible interactions the molecular organization of Idhp was investigated by the 
Blue Native gel-electrophoresis (Schägger et al., 1994). Conditions that allow detection of 
several other mitochondrial complexes and intermediates in the assembly of cytochrome c 
oxidase (Nijtmans et al., 1998) were used. Application of this technique to mitochondrial 
extracts of strain MMYO11 allowed the immunological detection of Idhp in a high molecular 
weight complex (Fig. 6). This complex possesses a higher molecular weight than cytochrome 
c oxidase (about 250 kDa) which was identified with antibodies directed against Cox3p. The 
exact size of the complex cannot be calculated from this experiment. Since both subunits were 
detectable (the original of Fig. 5 reveals two spots at the position of the Idhp signal) and since 
it is known that the protein is acting as an octamer the signal could reflect the molecular mass 
(about 320 kDa) of this multimeric form. Whether this complex consists of multimers of Idhp 
or of Idhp in association with other proteins remains to be elucidated. 
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Fig. 6: 2D PAGE of mitochondria from the wild type strain MMYO11 
Mitochondrial proteins of strain MMYO11 were analysed in a 2D BNE (first dimension)-SDS 
(second dimension) gel system. After Western blotting, successive immunodetections with 
antibodies against Cox3p and against Idhp were performed. Arrows indicate the direction of 
BNE- and SDS-PAGE electrophoresis. The positions of Idhp and Cox3p are indicated on the 
left. 
3.3 Identification of RNA-binding activities in idh2 null mutant strains 
Cit1p and Mdh1p are RNA-binding proteins. 
To identify and characterise proteins, which might be involved in the regulation of 
mitochondrial translation, the gel retardation assay established for Idhp was used 
(Papadopoulou et al., 1990). Since the Krebs cycle enzyme Idhp binds with high affinity to 
mitochondrial mRNAs and could possibly cover other binding activities, mitochondrial 
extracts from an idh2 null mutant strain were compared in retardation experiments with 
extracts from idh2cit1 and idh2mdh1 null mutants. Deletions of cit1 and mdh1 encoding 
citrate synthase1 and malate dehydrogenase1 were chosen because preliminary results 
indicated that Cit1p and Mdh1p are able to bind mitochondrial mRNAs. Surprisingly cit1 or 
mdh1 mutations, occurring in the absence of either one or both Idh subunits, have been 
reported to suppress the idh null mutation phenotype (Gadde and McCammon, 1997). Since 
Cit1p and Mdh1p are members of the same biochemical pathway as isocitrate dehydrogenase 
this observation is unexpected and could hint at an additional function of Cit1p and Mdh1p, 
eventually with respect to the RNA-binding function of Idhp . Whether Cit1p and/or Mdh1p 
are involved in RNA-binding was tested in the following way: mitochondrial proteins of the 
different idh null mutant strains were purified as described in Materials and Methods (2.1.5). 
The fractions eluted from Heparin Sepharose by increasing KCl concentrations were 
incubated with [α-32P] labelled RNA which contains the complete 5’-untranslated region and 
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part of the coding sequence of COX2 (termed as COX2 leader RNA) (Fig. 7A). The COX2 
leader is the shortest mitochondrial leader and therefore especially suited for direct protein-
RNA interaction studies by band-shift assays. The integrity of COX2 leader RNA was 
analysed on a 6 % polyacrylamide-7M urea gel and visualized by autoradiography (data not 
shown). Probably due to alternative secondary structures in addition to a major band several 
additional bands can be detected (lane 1). All fractions from the ∆idh2 null mutant strain 
I2∆HL show binding to the COX2 mRNA (lanes 2-5). Whereas the first two fractions of the 
∆idh2∆cit1 double null mutant strain I2∆CIT1L (lanes 6 and 7) still show a RNA band-shift 
similiar to that of first fractions of I2∆HL (lanes 2 and 3), no or strongly decreased RNA-
binding was observed in the respective fractions of the ∆idh2∆mdh1 double null mutant strain 
I2∆MDH1L (lanes 10 and 11). Comparison of the band-shifts of the last two fractions of each 
strain reveals similar RNA-binding activities of I2∆HL (lanes 4 and 5) and I2∆MDH1L (lanes 
12 and 13) but significantly reduced RNA-binding activity in the respective I2∆CIT1L 
fractions (lane 8 and 9) suggesting that the RNA-binding may be caused by Cit1p. To 
determine whether the RNA-binding properties correlate with the enzymatic activities of 
Cit1p and Mdh1p enzyme assays of all Heparin Sepharose fractions were performed. Highest 
specific activities of Mdh1p were found in the first two fractions and highest specific 
activities of Cit1p were found in the last two fractions. Obviously the RNA-binding activities 
correlate with the enzymatic activities (Fig. 7B). Therefore it seems likely that the observed 
protein-RNA complex formation of idh2 null mutant lysates is mediated by Cit1p and/or by 
Mdh1p. As malate dehydrogenase activity is also present in the last two elution fractions of 
I2∆CIT1L Mdh1p might be responsible for the residual band shift. However the presence of 
other binding proteins cannot be excluded. 
Complexes were also formed with the doubled concentration of competitor RNA (2 µg) and at 
4, 30 and 37°C (data not shown), indicating that the in vitro RNA-binding is specific. To gain 
insight into the nature of the interactions involved in the binding of Cit1p and Mdh1p to 
COX2 leader RNA, the effect of increasing amounts of KCl and Heparin on Cit1p/Mdh1p-
COX2 RNA-binding was determined (data not shown). Formation of both complexes proved 
to be resistant to high KCl concentrations (200 mM) indicating that ionic interactions do not 
play a prominent role in the binding of Cit1p and Mdh1p. The polyanion Heparin interfered 
with the formation of both complexes, but only at moderate to high concentrations (600-   
6000 nM). The ability of Heparin to completely inhibit Cit1p/Mdh1p-COX2 RNA-binding 
may reflect that hydrophobic interactions are involved in these protein-RNA interactions.  
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Fig. 7: COX2 RNA-binding activities in vitro correspond to enzymatic activities of Cit1p 
and Mdh1p 
Binding assays were performed using [α-32P] labelled COX2 leader RNA (ca. 2 ng) made in 
vitro by a T7 transcription system and mitochondrial protein fractions (1 µg) eluted from 
Heparin Sepharose as described in Materials and Methods. After mobility shift assay, 
radioactive material was visualized by autoradiography. 
(A) Lane 1, free RNA; lanes 2–5, RNA with protein fractions of I2∆HL, lanes 6-9, RNA with 
protein fractions of I2∆CIT1L, lanes 10-13, RNA with protein fractions of I2∆MDH1L. 
(B) All fractions were assayed for citrate synthase (light columns) and/or malate 
dehydrogenase (dark columns) activity. Specific enzymatic activities are mean values of 3 
independent measurements. 
3.4 Effect of cit1 and mdh1 null mutations on mitochondrial translation  
products 
Gel retardation assays indicated that the Krebs cycle enzymes Cit1p and Mdh1p are able to 
bind COX2 leader RNA independent of Idhp and therefore might also be involved in 
regulation of mitochondrial translation. To assess the effect of Cit1p and Mdh1p on 
mitochondrial translation, newly synthesised proteins in mitochondria isolated from the wild 
type, an idh2 null mutant, and from cit1 and mdh1 null mutants were compared in a pulse-
labelling experiment (Fig. 8A). Samples were taken after 30 and 60 min labelling using        
L-[35S] methionine and after 60 min chase in the presence of unlabelled methionine. Equal 
amounts of mitochondrial proteins were separated by SDS-PAGE and then blotted to a PVDF 
membrane. Labelled translation products were analysed by phosphorimager scannning. The 
results presented in Fig. 8A show that in the absence of Cit1p (panel ∆cit1) and Mdh1p (panel 
∆mdh1), the synthesis of mitochondrially encoded proteins seems to be not influenced. 
Synthesis of Cox2p and Cox3p (Fig. 8A; lanes 30/60 min pulse of wt, ∆cit1 and ∆mdh1) and 
their stability (Fig. 8A; lanes 60 min chase of wt, ∆cit1 and ∆mdh1) are comparable to wild 
type. The increase of Cox3p synthesis and its enhanced degradation in the idh2 null mutant 
(panel ∆idh2) is hardly detectable. Since not only synthesis and turnover but also the steady-
state levels of mitochondrial proteins are affected in mitochondria lacking the Krebs cycle 
enzyme Idhp, the steady-state level of Cox3p was analysed, too (Fig. 8B). The concentration 
of the ATP-ADP carrier Aac1p, which was used as an control, shows in all lanes comparable 
protein concentrations (Fig. 8B). While Cox3p is hardly detectable in an idh2 null mutant 
(panel b), strains lacking cit1 (panel c) and mdh1 (panel d) show wild type level (panel a). 
These data indicate that both Cit1p and Mdh1p are not directly involved in mitochondrial 
translation. 
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Fig. 8: Influence of null mutations of Krebs cycle enzymes on mitochondrial protein 
synthesis 
Mitochondrial translation products of MMYO11 (wt), I2∆HL (∆idh2), ∆CIT1L (∆cit1) and 
∆MDH1L (∆mdh1) were labelled with L-[35S] methionine for 60 min, followed by the 
addition of an excess of unlabelled methionine and a 60 min chase. Samples were taken after 
30 and 60 min labelling and after 60 min chase, separated by a 12.5 % SDS-PAGE and 
blotted on a membrane. 
(A) Newly synthesised proteins were analysed by phospho-imaging. The cytochrome c 
oxidase subunits Cox1p, Cox2p and Cox3p are indicated on the right. 
(B) Immunodetections were performed using a monoclonal antibody against Cox3p. As a 
control, the blot was incubated with an antibody against Aac1p. 
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3.5 Functional analysis of C-terminally tagged forms of Cit1p and Mdh1p 
Since no antibodies directed against Cit1p and Mdh1p were available, epitope-tagged variants 
of the CIT1 and MDH1 genes were constructed. Tagging of these proteins could change their 
native structure and affect their enzymatic function, although so far such effects have not been 
reported The functionality of histidine-tagged Cit1p and Mdh1p was analysed by 
complementation analysis and enzyme assays. The recombinant proteins were isolated from 
yeast mitochondria using affinity chromatography with Ni-NTA and tested for their ability to 
bind to RNA. Because the His6 antibodies also react with a number of proteins, which contain 
less than a series of six histidines, they cannot be used for immunoblots. Therefore in addition 
the HA-epitope was used and the participation of Cit1p and Mdh1p in high molecular weight 
complexes was analysed using protein-HA fusions. 
3.5.1 Complementation analysis of Cit1p and Mdh1p 
Tagging of Cit1p and Mdh1p does not affect the ability to complement the mutant growth 
phenotype. 
The epitope tag HA was placed at the C-terminus of the investigated proteins (pGH1-Cit1p-
HA; pGH7-Mdh1p-HA). To be able to purify Cit1p and Mdh1p from whole cell lysates in a 
one step procedure, the proteins were C-terminal fused to six histidine residues (pGH1-Cit1p-
His6; pGH7-Mdh1p-His6). Mutants lacking Cit1p or Mdh1p are unable to grow on the non-
fermentable carbon source acetate. Functionality of the fusion proteins was tested by 
transformation of the respective genes into ∆CIT1L or ∆MDH1L and analysis of the acetate 
growth characteristics of the resulting transformants. As a positive control the wild type strain 
MMYO11 was used. As negative controls the cit1 and mdh1 null mutant strains and the cit1 
and mdh1 null mutant strains transformed with the vector pGH1 or pGH7 were used. As 
presented in Fig. 9 transformants containing one of the vectors do not restore growth on 
acetate, whereas transformants bearing the HA- or His6-tagged genes do. This observation 
shows that the tagging of Cit1p and Mdh1p does not disturb their functionality. 
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Fig. 9: Complementation of the acetate- phenotype of strains ∆CIT1L and ∆MDH1L 
Strain ∆CIT1L was transformed with pGH1 as a negative control or with plasmids encoding 
Cit1p-HA or Cit1p-His6. Strain ∆MDH1L was transformed with pGH7 as a negative control 
or with plasmids encoding Mdh1p-HA or Mdh1p-His6. Strain MMYO11 served as a positive 
control. All strains were grown overnight in liquid minimal medium supplemented with 
selective amino acids and resuspended to 2 units OD600. This suspension was serially diluted 
in 10-fold steps. For each strain, 5 µl from each dilution were spotted onto rich medium with 
acetate as a carbon source (YPAce). Growth of cultures on acetate medium was monitored 
after 3 days of incubation at 30°C. 
3.5.2 Affinity purification of Cit1p and Mdh1p 
Proteins, which were purified from whole cells disrupted with glass beads, showed an 
increased instability. Possibly not all proteases could be inactivated and caused the 
degradation. For that reason mitochondria of cit1 or mdh1 null mutant strains transformed 
with the plasmids pGH1-Cit1-His6 or pGH7-Mdh1-His6 were isolated, lysed and used for 
affinity purification. Western blot analysis (Fig. 10A) shows that both Cit1p-His6 (49 kDa; 
lane 2) and Mdh1p-His6 (33 kDa; lane 3) could successfully be isolated. The molecular mass 
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is consistent with that wild type protein plus additional six histidine residues. The purity of 
the recombinant proteins was high as deduced from silver staining of the gels. Whether the 
conditions of the affinity chromatography permit a copurification of interacting proteins was 
investigated by enzyme assays. Indeed, this approach revealed that the purified Cit1p-His6 
contains tiny amounts of Mdh1p and the purified Mdh1p-His6 shows traces of Cit1p activity. 
Idh activity was not detected. To exclude the possibility of copurification the His-tagged 
construct of CIT1 was transformed into the ∆mdh1-strain Y04934, while the His-tagged 
construct of MDH1 was transformed into the ∆cit1-strain Y05376. The recombinant proteins 
were isolated from yeast mitochondria according to the protocol for affinity chromatography 
(2.2.6). Purity was examined by means of gel staining with silver nitrate (Fig. 10B). In 
contrast to the pre-vious purification two bands for each protein (lane 3; Cit1p-His6 and lane 
6; Mdh1p-His6) were observed. Because Cit1p and Mdh1p are present in vivo as dimers 
(Musrati et al., 1998; Reif et al., 2001) the result probably reflects copurification of tagged 
and untagged proteins. 
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Fig. 10: Purification of C-terminally His-tagged Cit1p and Mdh1p from the corres-
ponding null mutants 
The C-terminally His-tagged forms of Cit1p and Mdh1p were affinity purified using 
chromatography on Ni-NTA and silver stained after electrophoresis on 12.5 % SDS 
polyacrylamide gel. 
(A) Cit1p-His6 and Mdh1p-His6 were expressed in the corresponding null mutant strains 
∆CIT1L and ∆MDH1L. Lane 1, purified Cit1p-His6, lane 2, purified Mdh1p-His6. 
(B) Cit1p-His6 was expressed in the ∆mdh1-strain Y04934 and the Mdh1p-His6 was 
expressed in the ∆cit1-strain Y05376. Lane 1, mitochondrial lysate prior to incubation with 
Ni-NTA, lane 2, mitochondrial lysate after incubation with Ni-NTA, lane 3, purified Cit1p 
His6, lane 4, mitochondrial lysate prior to incubation with Ni-NTA, lane 5, mitochondrial 
lysate after incubation with Ni-NTA, lane 6, purified Mdh1p His6. 
3.5.3 Enzymatic activity of Cit1p and Mdh1p 
Tagging does not affect the catalytic activity of Cit1p and Mdh1p. 
Cit1p and Mdh1p carry out catalytic functions in the Krebs cycle. To test whether epitope-
tagged forms of these proteins act like wild type enzymes, recombinant Cit1p-His6 and 
Mdh1p-His6 were assayed for their enzymatic activity. The specific activities measured for 
the affinity-purified enzymes (Table 6) are similar to that obtained by conventional methods 
(Srere et al., 1963; McAlister-Henn and Thompson, 1987). This result suggests that the fusion 
of six histidines does not interfere with the enzymatic function of Cit1p and Mdh1p. 
 
Table 6: Specific enzymatic activities of purified enzymes 
Enzymes were purified in form of His-tagged proteins. Cit1p was expressed in the ∆mdh1-
strain Y04934, Mdh1p in the ∆cit1-strain Y05376. Citrate synthase or malate dehydrogenase 
activitiy was determined in triplicate. 
 
 
Protein Cit1p-His6 Mdh1p-His6 
Specific activity 
(U/mg) 
 
129.75 
 
143.41 
 
3.5.4 Analysis of protein-protein interactions of Cit1p and Mdh1p 
Cit1p and Mdh1p do not interact with mitochondrial proteins. 
To detect possible interactions between Krebs cycle enzymes or respiratory chain subunits 
and Cit1p and Mdh1p by 2D Blue Native gel-electrophoresis mitochondrial proteins from 
∆CIT1L transformed with pGH1-Cit1p-HA, and from ∆MDH1L transformed with pGH7-
Mdh1p-HA, were applied to a BN-PAGE in the first dimension and then separated by SDS-
PAGE in a second dimension. Proteins were analysed by immunoblotting with monoclonal 
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antibodies against HA and Cox3p. The detection of Cit1p-HA (Fig. 11A) and Mdh1p-HA 
(Fig. 11B), respectively, revealed at the same position in the first dimension a strong signal 
and a number of further spots probably caused by degradation products. An additional weak 
signal for both proteins is observed. Dimerisation experiments of Cit1p showed that almost all 
monomers assemble into dimers (Reif et al., 2001). Since Mdh1p forms dimers as well, the 
strong signal probably represents the dimeric form, while the weak signal might reflect the 
monomeric form. An additional signal (marked with an asterisk) results from a protein 
crossreacting with the HA-antibody. This protein is also detected in lysates lacking HA-
epitope containing proteins. Cox3p indicates the position of the COX complex (about         
250 kDa). Regarding the location of COX it can be assumed that Cit1p and Mdh1p are 
localised in a mitochondrial complex with a molecular weight lower than 250 kDa. However, 
existence of weak interactions with other proteins, which are disrupted by the extraction or 
separation techniques used, cannot be ruled out. 
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Fig. 11: Localisation of Cit1p and Mdh1p 
Mitochondrial proteins of ∆CIT1L transformed with pGH1-Cit1p-HA (A) and of ∆MDH1L 
transformed with pGH7-Mdh1p-HA (B) were analysed in a 2D BNE (first dimension)-SDS 
(second dimension) gel system. After Western blotting, successive immunodetections with 
antibodies against the HA-Epitope and against Cox3p were performed. Arrows indicate the 
direction of BNE and SDS-PAGE electrophoresis. The positions of Cit1p-HA and Cox3p are 
indicated on the left. The crossreacting signal of the HA-antibody is marked with an asterisk. 
3.5.5 Cit1p-His6 and Mdh1p-His6 bind to COX2 leader RNA 
His-tagged forms of Cit1p and Mdh1p bind to RNA. 
As shown by complementation analysis (3.5.1) growth on acetate as sole carbon source was 
restored by transformation of the null mutants with pGH1-CIT1-His6 or pGH7-MDH1-His6. 
Obviously the histidine-tagged forms of Cit1p or Mdh1p perform normal metabolic functions 
in vivo. When Cit1p-His6 and Mdh1p-His6 were analysed for in vitro RNA-binding using the 
COX2 leader probe, complexes were formed (Fig. 11, lanes 2 and 3). This suggests that the 
presence of the C-terminal His-tag does not interfere with RNA-binding. Whether the      
histidine residues by themselves mediate RNA-binding was controlled by His-tagged EGFP 
(enhanced green fluorescent protein), which is often used to investigate protein localisation 
(lane 4). At a protein concentration of 1 µg retarded bands which are comparable to those 
mediated by the untagged enzymes were observed. Although a clear retardation was achieved 
with a less amount of protein (data not shown) 1 µg of affinity purified protein was used in 
the following experiments. This concentration seems to be sufficient to saturate all RNA-
binding sites because higher protein concentrations did not result in a increase in the observed 
band shift. His-tagged EGFP did not lead to retardation of the RNA. 
 
 
Results 
 54 
 
 
 
Fig. 11: RNA-binding analysis of histidine tagged proteins 
RNA-binding activities of Cit1p-His6 (lane 2) and Mdh1p-His6 (lane 3) were assessed in a gel 
retardation assay with radiolabelled COX2 leader RNA from S. cerevisiae (lane 1). RNA-
protein complexes were separated in a 4 % native polyacrylamide gel and visualised by 
autoradiography. His-EGFP (lane 4) served as a negative control. 
3.6 Specificity of Cit1p/Mdh1p RNA-binding 
The secondary structure of mitochondrial mRNAs may define the target site of Cit1p and 
Mdh1p. 
In the previous chapters it has been demonstrated that Cit1p and Mdh1p exhibit binding to an 
RNA encompassing the 5’ untranslated leader and a small part of the coding region of COX2. 
To study the binding specificity of the proteins, the gel retardation assay with COX2 transcript 
was performed in the presence of homologous and heterologous RNAs. As competitors the 
unlabelled transcripts of COX2 leader (-54 to +50), COB leader (-343 to -26) and COX2 gene 
including the leader (-54 to +756) from S. cerevisiae (Fig. 2 in Materials and methods) were 
used, tRNA from yeast served as unspecific competitor. The effect of the preincubation with 
the respective RNA on radiolabelled RNA-protein complex formation was determined with 
histidine-tagged proteins (Fig. 12). In the presence of increasing amounts of unlabelled COX2 
leader RNA with a constant amount of labelled COX2 leader RNA the complexes were 
similarly diminished (lanes 3-6). Increasing molar excess of unlabelled COB leader RNA 
(lanes 7-10) caused a stronger competition than the addition of COX2 leader RNA, while 
increasing molar amounts of COX2 leader/gene RNA (lanes 11-14) caused the strongest 
competition. The protein binding to the labelled RNA was inhibited in the order: COX2 
leader/gene > COB leader > COX2 leader RNA, when each compound was tested at 1, 5, 10 
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and 50-fold molar excess. These results indicate that Cit1p and Mdh1p are capable of 
interacting specifically with mitochondrial mRNAs. Since antisense transcripts made from 
COB leader RNA and from COX2 leader/gene RNA have the same affinity for the proteins 
like the sense RNAs, Cit1p and Mdh1p seems to select a secondary structure motif that is 
common in both RNA species. These experiments also confirmed the findings with partially 
purified proteins (data not shown) that there is a specific interaction between the investigated 
Krebs cycle enzymes and mitochondrial RNAs. Since all transcripts have different sizes (from 
104 nt for COX2 leader to 810 nt for COX2 leader/gene) and can presumably fold in different 
secondary structures, additional studies are needed to elucidate possible sequence/structure 
requirements for Cit1p and Mdh1p binding. 
In contrast, preincubation with the non-specific competitor tRNA had no significant effect on 
the level of protein interaction with the COX2 probe. A 1000-fold molar excess of tRNA 
referring to the COX2 leader RNA slightly diminished the retardation of the RNA but did not 
compete (lanes 15). 
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B 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Cox2 leader / / 1 5 10 50 / / / / / / / /  
Cob leader / / / / / / 1 5 10 50  / / /  
Cox2 leader/gene / / / / / / / / / / 1 5 10 50  
tRNA / / / / / / / / / / / / / / 1000 
 
 
 
complex                                        ! 
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Fig. 12: Competition analysis of COX2 RNA-binding by Cit1p-His6 and Mdh1p-His6 in 
vitro 
Increasing amounts of unlabelled competitor RNAs were mixed with the histidine-tagged 
proteins prior to the addition of labelled COX2 probe. 
(A) Mobility shift of COX2-Cit1p-His6. Lane 1, free RNA; lane 2, complex formation bet-
ween COX2 RNA and Cit1p-His6, lane 3-6, competition with unlabelled COX2 leader RNA, 
lane 7-10, competition with unlabelled COB leader RNA, lane 11-14, competition with 
unlabelled COX2 leader/gene RNA, lane 15, competition with yeast tRNA. The molar excess 
of competitor over the labelled RNA is given. 
(B) Mobility shift of COX2-Mdh1p-His6. Lane 1, free RNA; lane 2, complex formation bet-
ween COX2 RNA and Mdh1p-His6, lane 3-6, competition with unlabelled COX2 leader RNA, 
lane 7-10, competition with unlabelled COB leader RNA, lane 11-14, competition with 
unlabelled COX2 leader/gene RNA, lane 15, competition with yeast tRNA. The molar excess 
of competitor over the labelled RNA is given. 
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3.7 Influence of cofactors and substrates on Cit1p/Mdh1p RNA-binding 
It has been shown for other RNA-binding proteins, for instance glyceraldehyde-3-phosphate 
dehydrogenase, catalase and glutamate dehydrogenase that the RNA-binding activity can be 
inhibited by cofactors or allosteric ligands (Nagy and Rigby, 1995; Clerch et al., 1996; 
Bringaud et al., 1997). Since both citrate synthase and malate dehydrogenase activities are 
regulated by several nucleotide effectors, whose levels fluctuate dependent on the energy state 
of the mitochondria, the influence of acetyl-CoA, AMP/ATP and NAD+/NADH on the RNA-
binding capacity of Cit1p or Mdh1p was investigated. The effect of an incubation with the 
substrates oxaloacetate, citrate or malate on RNA-binding activities of Cit1p or Mdh1p was 
also examined. The cofactors or substrates were added to the binding reaction in high molar 
excess (final concentrations indicated in Fig. 13 and 14). The effect on RNA-binding was 
assayed by mobility shift analysis. As shown in Fig. 13, a concentration of 5 mM of acetyl-
CoA (lane 4) and ATP (lane 10) decreased Cit1p and Mdh1p binding of [α-32P] labelled 
COX2 leader, whereas a concentration of 5 mM of AMP (lane 7), NAD+ (lane 13) and NADH 
(lane 16) did not affect the RNA-binding. An effect of the latter substances on complex 
formation can be observed when higher concentrations (50 mM) are used. Since these 
concentrations affect the mobility of free RNA as well, this effect is likely to be artefactual. 
Band shift analysis of Cit1p-His6 and Mdh1p-His6 in the presence of oxaloacetate (lanes 19), 
of citrate or malate (lanes 22) showed that binding is also inhibited at a concentration of       
50 mM. In that case mobility of free RNA was not altered. These data indicate that the 
substrate acetyl-CoA and the cofactor ATP may regulate RNA-binding by both enzymes to 
the COX2 leader. The specifity of these inhibitory effects on Cit1p/Mdh1p-RNA interactions 
was supported by the effect of acetyl-CoA and ATP on RNA-binding activities of partially 
purified proteins (data not shown). The other substrates or cofactors are probably not involved 
in the regulation of RNA-binding. 
 
 
 
 
 
 
 
 
 
 
 34 
 
                        
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
acetyl-CoA / / 0.5 5 50 / / / / / / / / / / / / / / / / / / 
AMP / / / / / 0.5 5 50 / / / / / / / / / / / / / / / 
ATP / / / / / / / / 0.5 5 50 / / / / / / / / / / / / 
NAD+ / / / / / / / / / / / 0.5 5 50 / / / / / / / / / 
NADH / / / / / / / / / / / / / / 0.5 5 50 / / / / / / 
oxaloacetate / / / / / / / / / / /  / / / 0.5 5 50 / / / 
citrate / / / / / / / / / / /  / / / / / / 0.5 5 50 
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Fig. 13: Influence of various factors on RNA-binding of C
COX2 RNA was incubated without (lane 1) and with 1 µg d Cit1p-His6 (lane 2). Lanes 3-23 acetyl-
CoA, AMP, ATP, NAD+, NADH, oxaloacetate or citrate ed to the binding reactions in the final
concentrations as indicated in the figure (in mM). 
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 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
acetyl-CoA / / 0.5 5 50 / / / / / / / / / / / / / / / / / / 
AMP / / / / / 0.5 5 50 / / / / / / / / / / / / / / / 
ATP / / / / / / / / 0.5 5 50 / / / / / / / / / / / / 
NAD+ / / / / / / / / / / / 0.5 5 50 / / / / / / / / / 
NADH / / / / / / / / / / / / / / 0.5 5 50 / / / / / / 
oxaloacetate / / / / / / / / / / / / / / / / / 0.5 5 50 / / / 
malate / / / / / / / / / / / / / / / / / / / / 0.5 5 50 
 
 
 
 
 
 
 
complex ! 
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 Fig. 14: Influence of various factors on RNA-binding of Mdh1p 
COX2 RNA was incubated without (lane 1) and with 1 µg of purified Mdh1p-His6 (lane 2). Lanes 3-23 acetyl-
CoA, AMP, ATP,  NAD+, NADH, oxaloacetate or malate were added to the binding reactions in the final
concentrations as indicated in the figure (in mM). 
 
Discussion 
 60 
 
4 DISCUSSION 
4.1 Characterisation of Idhp by mutant forms 
The ability of Idh1 mutant proteins to confer normal respiratory growth was tested in the 
∆idh1 strain ∆IDH1L. While the enzymatic mutant protein Idh1pS92A is not able, the RNA-
binding deficient protein Idh1pK182L/Y184N is able to substitute the wild type Idh1p (3.1.1). To 
exclude the possibility that protein degradation led to the inability of Idh1pS92A to substitute 
the wild type Idh1p, Western blot analysis of the transformants was performed. Both 
Idh1pS92A and Idh1pK182L/Y184N were detectable (3.1.2). Compared to wild type Idh1p the 
steady state concentration of the mutant proteins is reduced, probably caused by degradation. 
As evident from the complementation analysis (3.1.1) the decreased amount of mutant 
Idh1pK182L/Y184N is still sufficient for complementation of an idh1 null mutation. Therefore, it 
seems unlikely that the reduction in the concentration can account for the inability of the 
enzymatic mutant protein Idh1pS92A to complement strain ∆IDH1L. 
On the basis of kinetic analysis of Idh1pS92A and Idh2pS98A, in which a conserved serine 
residue at the proposed active site of each subunit was mutated to alanine, Cupp and 
McAlister-Henn (1993) presented a model which proposed that Idh1p functions as a 
regulatory subunit while Idh2p functions in catalysis (Fig. 15). This model was supported by 
characterisation of conserved aspartate and isoleucine residues (Zhao and McAlister-Henn, 
1997) within regions known to participate in cofactor binding in other NAD+-specific 
dehydrogenases (Imada et al., 1991). From these results it was concluded that Idh1p contains 
residues necessary for cooperative binding of isocitrate and AMP and thus appears to be the 
primary contributor to regulatory function. Idh2p, in contrast, appears to contribute primarily 
to catalytic binding of isocitrate and NAD+. Consistent with this catalytic function, alterations 
within the putative isocitrate binding site of Idh2p have much more dramatic effects on 
catalysis than do analogous substitutions in Idh1p (Lin et al., 2001). Amino acid residue 
replacements in the putative isocitrate binding site of Idh1p have much more moderate effects 
on catalysis, but many of them significantly reduce the apparent affinity for isocitrate (Lin et 
al., 2001). This result points to a binding of isocitrate by the Idh1p site without catalytical 
alteration of isocitrate. All these data would explain why a disturbed regulation by Idh1p 
prevents the catalytic activi-ty of Idh2p and by that the energy production for a functional 
respiratory chain. 
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Fig. 15: Schematic presentation of important amino acids of Idhp 
Studies of mutant enzymes suggest the involvement of defined amino acid residues in the 
enzymatic and the RNA-binding function of Idhp. The possible roles of the different subunits 
are indicated, (Zhao and McAlister-Henn, 1997; modified). 
 
 
Another possibility besides a regulatory effect of Idh1p on the catalytic function of Idh2p 
would be that alterations in the active site of Idh1p could disrupt the interactions between both 
subunits. As both subunits are necessary for enzymatic activity (Cupp and McAlister-Henn, 
1992) functionality is only guaranteed by proper interactions and therefore missing 
interactions could lead to the respiratory deficient phenotype. Most of the structural subunit 
interactions in the holoenzyme involve heterologous subunit interactions. This is suggested by 
the monomeric state of either Idh1p or Idh2p isolated from yeast mutants lacking the other 
subunit (Cupp and McAlister-Henn, 1992). Results from a yeast two-hybrid system indicate 
strong interaction between Idh1p and Idh2p, but no detectable interactions between identical 
subunits (Panisko and McAlister-Henn, 2001). In line with this observation Cupp and 
McAlister-Henn (1993) showed that mutant proteins assemble into heteromeric octameric 
complexes similar to wild type. 
The result that the Idh1pS92A active site mutant expressed in single- and in multi-copy is not 
able to complement an idh1 null mutation (data not shown) suggests that the serine residue at 
position 92 in the isocitrate binding site of Idh1p is very critical for its function. The effect of 
the S92A mutation is remarkable, because transformants expressing other Idh1p active site 
mutant enzymes grow well on glycerol medium (Lin et al., 2001), thus indicating no 
significant effect on growth due to altered kinetic properties associated with the specific 
residue replacements. 
RNA-BINDING  
Lys-182 
Tyr-184 
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The observation that the RNA-binding deficient mutant protein Idh1pK182L/Y184N is able to 
confer growth on glycerol could be explained it reduced RNA-binding efficiency is only 
effective in vitro and not in vivo. Alternatively, the reduced RNA-binding efficiency may be 
sufficient to form an active respiratory chain. 
To analyse the in vivo situation in mitochondria, protein labelling experiments of 
transformants expressing either the enzymatic mutant protein Idh1pS92A or the RNA-binding 
deficient protein Idh1pK182L/Y184N were performed (3.1.3). Whereas in organello labelling did 
not reveal any differences between those two mutants, the steady-state level of Cox3p proved 
to be different. Thus the RNA-binding mutant shows the same Cox3p level like the wild type 
consistent with the findings of the complementation experiment that RNA-binding deficiency 
of Idh1p obviously does not play a major role in regulation of mitochondrial function. But the 
enzymatic activity of Idh1p, perhaps in combination with its regulatory function, seems to be 
important. Thus the enzymatic mutant shows reduced Cox3p levels similar to that obtained 
from an idh1 null mutant strain. In both cases Cox3p seems to be less stable than in wild type 
cells. Data of synthesis and assembly of mitochondrially encoded proteins could provide an 
explanation for that: in the absence of Idh1p both synthesis and degradation of Cox3p is 
enhanced (de Jong et al., 2000). Furthermore only a small fraction of the newly synthesised 
Cox3p is assembled into cytochrome c oxidase whereas unassembled protein is rapidly 
degraded (de Jong et al., 2000). The reduced amounts of Cox3p may point to an increased 
degradation, while the instability of Cox3p could explain this degradation by unassembling. 
To a further characterisation of the enzymatic mutant steady-state levels of other proteins like 
Cox1p and Cox2p, which are dramatically decreased in an idh1 null mutant strain should be 
defined. 
If an enzymatic mutant behaves like an idh1 null mutant strain, the questions arise: Why does 
the mutant show this behaviour? Is the enzymatic function of Idhp regulated ? The enzymatic 
activity of Idhp can be inhibited by the addition of target mRNAs (Anderson et al., 2000; 
Elzinga et al., 2000). This inhibition is relieved by the presence of the allosteric activator 
AMP (Anderson et al., 2000), indicating that the mitochondrial AMP level can determine the 
switch between enzymatic and RNA-binding function. On one hand if the Idh1p is not able to 
switch to the RNA-binding function due to a mutation in the active site, the protein cannot act 
as translational repressor (de Jong et al., 2000). Thus the synthesis of mitochondrial products 
would be disturbed and their subsequent assembly into functional respiratory complexes 
prevented. On the other hand if a mutation of the Idh1p prevents an interaction with Idh2p the 
holoenzyme also loses its RNA-binding facility. The observation that neither (di-) nucleotide 
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cofactors nor the substrate, isocitrate, regulate RNA-binding (Elzinga et al., 1993) suggests 
that regions distinct from the dinucleotide binding site and from the active site are involved in 
binding RNA. May be an interdependence of both subunits during enzymatic and/or RNA-
binding activity is required. 
It cannot be ruled out that the regulation of enzymatic and/or RNA-binding activity is due to 
modification of the enzyme, as is shown for NADP+-Idhp from E. coli. In this case the 
enzymatic activity is regulated by preventing the binding of isocitrate by phosphorylation of 
the active site (Dean et al., 1989; Hurley et al., 1990). It was mentioned by these authors that 
yeast mitochondrial NAD+-Idhp is not subjected to any post-translational modification (Fox, 
1996). However, close examination of a two dimensional SDS-PAGE using iso-electric 
focussing in the same paper reveales a minor spot for Idh1p, which could be an indication of a 
post-translational modification of this subunit. 
It is still not known whether Idhp binds to RNA as part of the metabolon or as its own. The 
gel retardation assays indicate that isolated Idhp - at least in vitro - is able to bind RNA 
independent of other Krebs cycle enzymes. Although there exists an interdependence of the 
Krebs cycle enzymes within the intact mitochondrion (Beeckmans and Kanarek, 1987) this 
interdependence looks different compared to the picture drawn in the following paragraph. 
Thus, if the function of one part of the cycle is blocked the function of the entire cycle appears 
to be blocked (Kispal et al., 1989; Sümegi et al., 1992a, 1992b). 
Gadde and McCammon (1997) made the interesting observation that yeast strains with idh2 
nonsense or null mutants grow very poorly on glycerol. These mutants have a strong tendency 
to accumulate extragenic mutations, termed glycerol suppressors, that enhance growth on this 
non-fermentable carbon source. Missense, nonsense and null mutations at the CIT1 locus 
encoding mitochondrial citrate synthase, were the most common suppressors identified. In 
addition to Cit1p, mutations in 3 other Krebs cycle enzymes are capable of suppressing idh2 
mutations. Genetic evidence shows that glycerol suppressor mutations only occur in idh 
deficient mutants, indicating that Idhp plays a unique role in S. cerevisiae growing on 
glycerol. Mutations in other Krebs cycle enzymes do not give rise to suppressor mutations 
(Przybyla-Zawislak et al., 1999) which indicates that a defective Krebs cycle does not lead to 
these mutations. It is more likely that instead of a defective enzymatic function a defective 
RNA-binding function of Idhp gives rise to suppressor mutations which might compensate for 
the absence of the Idhp RNA-binding function. Indeed, results presented in this work indicate 
that Cit1p and Mdh1p are able to bind mitochondrial mRNAs. 
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4.2 Localisation of Idhp 
The application of the 2D Blue native gel-electrophoresis has shown that Idhp is localised at a 
position corresponding roughly to a molecular mass of approximately 300 kDa (3.2). It is 
likely that this complex consists of a multimer of Idhp, since the molecular weight of the 
usual octameric form is 320 kDa and results from yeast two-hybrid assays and affinity 
chromatography indicate significant physical interaction between Idh1p and Idh2p subunits 
(Cupp and McAlister-Henn, 1993; Panisko and McAlister-Henn, 2001). But it cannot be 
excluded that this complex consists of Idhp which is associated with (an)other protein(s). On 
the one hand the Krebs cycle in which Idhp is a key regulatory enzyme seems to form a large 
complex (Robinson and Srere, 1985) and for some of the Krebs cycle enzymes like Cit1p and 
Mdh1p an interaction has been shown (Velot et al., 1999). On the other hand many of the 
mRNA specific translational activators display interaction with the mitochondrial ribosome 
(Fox, 1996) and are located at or near the inner mitochondrial membrane. Idhp as a 
mitochondrial RNA-binding protein could also exhibit interaction with the mitoribosome or 
inner membrane proteins. This assumption can be supported by the fact that the Krebs cycle is 
also localized at the inner mitochondrial membrane (Robinson and Srere, 1985), the site of the 
respiratory chain which is functionally connected with the Krebs cycle. Therefore association 
of Idhp with proteins of the Krebs cycle, of the mitochondrial respiratory chain complexes 
and/or of the mitoribosome is possible. The analysis of proteins in the complex could be 
performed by using antisera or by MaldiTOF. If a potential interacting protein is identified, 
this interaction can be verified by co-immunoprecipiation or two-hybrid assay. 
Recently a membrane-associated complex containing five intermembrane space-facing 
dehydrogenases, the matrix-facing NADH dehydrogenase, a part of the Krebs cycle including 
Idh2p and an additional NADH-producing enzyme has been identified (Grandier-Vazeille et 
al., 2001). Since theses authors also obtained information about potential interactions between 
this complex and other mitochondrial complexes, namely the bc1-complex, the colorless 
native polyacryamide gel-electrophoresis in combination with Edman degradation and mass 
spectrometry seems to be a suitable tool for the identification of physiological interactions 
between proteins. The procedure could also used to identify Idhp as a component associated 
to membrane complexes. 
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4.3 RNA-binding properties of Cit1p and Mdh1p  
In an attempt to look for RNA-binding proteins in the absence of Idhp an electrophoretic 
mobility shift with lysate from an idh2 null mutant strain was performed. Surprisingly, as 
demonstrated in this work, other RNA-binding proteins beside the potential candidates like 
the known translational activators are present in yeast mitochondria. 
The purification scheme permits at first an enrichment of enzymes because of the usage of 
Blue Sepharose. This material contains the dye, Cibacron Blue F3G-A, which has affinity for 
a wide variety of enzmyes. These include enzymes requiring adenyl-containing cofactors 
(including NAD+ and NADP+). In the next step an enrichment of nucleotide binding proteins 
is achieved due to Heparin Sepharose. Heparin shows a high content of anionic sulphate 
groups, which mimic the similarly polyanionic structure of nucleic acids. The expression of 
the mRNA specific translational activators of cytochrome b RNA as GST-fusion and 
histidine-tagged proteins pointed to a very low abundance in heterologous (E. coli) and in 
homologous (S. cerevisiae) systems (data not shown). Therefore it was unlikely to identify the 
translational activators among the RNA-binding proteins. Abundant proteins of the RNA-
binding fractions were chosen, subjected to N-terminal sequencing (data not shown) and 
identified Cit1p and Mdh1p as RNA-binding candidates. To test whether these proteins were 
responsible for the observed RNA-protein complexes, lysates of both an ∆idh2∆cit1 double 
null mutant strain and an ∆idh2∆mdh1 double null mutant strain were applied for mobility 
shift assays. In both cases, strongly reduced RNA-binding activities were detectable. Further 
evidence for Cit1p and Mdh1p being the RNA-binding proteins was provided by analysis of 
enzymatic acitivities. The RNA-binding and enzymatic activities clearly coincide. However, 
the presence of (an) additional RNA-binding protein(s) cannot be excluded. 
In mobility shift assays, competitor RNA is usually used to eliminate non-specific RNA-
protein interactions. The anionic polymer Heparin can also work as a non-specific competitor. 
The different competitors do not work equally well for all proteins and it is recommended to 
determine which of the competitors allows optimal binding of the protein. Sensitivity of Cit1p 
and Mdh1p RNA-binding to Heparin was unexpected. However, it reminds to the Heparin 
inhibition of RNA-binding of Idhp (Siep, 2001). At a concentration of 600 nM, which is 
similar to the concentration which inhibits Idhp RNA-binding, complex formation was nearly 
absent. In the previous studies this Heparin sensitivity was discussed as an indication for the 
involvement of electrostatic interactions between the RNA and positively charged protein 
domains (arginine clusters). This might be the case in our study, too. Band-shift assays of this 
work are routinely performed in the presence of 50 mM KCl. High salt concentrations       
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(200 mM) only slightly decrease complex formation of the RNA-binding components. This 
may indicate that the Cit1p-RNA and the Mdh1p-RNA interaction is not exclusively an 
electrostatic interaction and may be comparable to the features of the Idhp RNA-binding. 
Cit1p and Mdh1p bind to the same mitochondrial leader sequences of COX2 and COB (data 
not shown) like Idhp which might be an indication for a general RNA-binding affinity to 
leader RNAs as shown for Idhp. Nevertheless these proteins are probably highly selective in 
their ability to bind RNA since a concentration of 2 µg competitor E. coli RNA representing 
an excess of RNA molecules with different sizes and shapes to the 3-5 ng of labelled RNA did 
not compete.  
Thus, the conditions which were successfully used for the analysis of the specific interaction 
between Idhp and several 5’-untranslated regions of mitochondrial mRNAs were applicable to 
other factors that interact with such sequences. Not abundant protein(s) binding to the defined 
COX2 RNA would not have been identified. In such a case the RNA-binding protein(s) could 
be purified and characterised by affinity methods yielding sufficient protein for amino acid 
sequencing. This allows either the protein to be directly identified by its sequence, or the 
isolation of cDNA clones leading ultimately to the expression as recombinant protein. Three 
different methods currently in use for affinity purification of RNA-binding proteins, one 
dating back over 20 years, and two relatively modern technologies (Smith, 1998): 
(1) Direct covalent coupling of the RNA affinity substrate to CNBr-activated 
Sepharose 
(2) Poly(A) tailing to bind the RNA affinity substrate to poly(U)-Sepharose 
(3) Direct or indirect incorporation of biotinylated nucleotides to allow binding of the 
RNA affinity substrate to streptavidin which is itself covalently linked to a solid 
matrix. 
Except in the case of the poly(A) tailing method, the RNA element used as the affinity matrix 
should generally be larger than the minimal length required for binding the protein in 
question, to avoid the risk that the binding site may be masked by the coupling to the solid 
support. 
Based on the ability of RNA-binding proteins to interact in a stable fashion with RNA 
substrates while immobilised on solid support matrices such proteins can be detected and 
cloned. Detection of immobilised proteins with labelled RNA molecules is often referred to as 
“Northwestern” screening. Successful application of these methodologies can lead to the rapid 
identification and cloning of RNA-binding proteins like the RNA-binding protein G-rich 
sequence factor 1 (Qian and Wilusz, 1994) without the need for labour-intensive biochemical 
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purification and conventional cloning approaches. These methods, therefore, may be 
especially useful for characterising RNA-binding proteins of low abundance. 
4.4 Effects of Cit1p and Mdh1p on mitochondrial translation 
While the mRNA-specific factors activate the translation of one leader RNA, Idhp inhibits 
translation by binding to all leaders of mitochondrial RNAs. In cells lacking either one or both 
Idhp subunits, the Krebs cycle is blocked and synthesis of mitochondrial encoded products is 
activated because of the absence of translational repressor activity of Idhp (de Jong et al., 
2000). To study the potential role of the newly identified RNA-binding proteins Cit1p and 
Mdh1p in regulating translation in organello labelling of mitochondrial proteins in cells 
lacking either Cit1p or Mdh1p was performed (3.4). Both null mutants show wild type like 
synthesis and turnover indicating that Cit1p and Mdh1p are not acting as translational 
activators or repressors of mitochondrial mRNAs. Since the steady-state level of Cox3p is 
also comparable to that of the wild type strain, stability and/or assembly of mitochondrial 
translation products seems not to be disturbed. Taken together these data suggest that Cit1p 
and Mdh1p are not essential components of the mitochondrial translation machinery. 
So the question arises: What could be the meaning of Cit1p and Mdh1p RNA-binding? If they 
are not involved in the stabilization of mitochondrial mRNAs, which is supported by equal 
amounts of the respective RNAs in Northern blot analysis (data not shown), they could be 
involved in directing of mitochondrial mRNAs to locations where these RNAs are translated. 
Since in mammals the mitochondrial malate dehydrogenase binds to protein components of 
the mitochondrial inner membrane, namely to complex I (Sümegi and Srere, 1984) and citrate 
synthase binds to the pyruvate dehydrogenase complex (Sümegi and Alkonyi, 1983) which is 
also interacting with complex I (Sümegi and Srere, 1980), both proteins may be located near 
the mitochondrial inner membrane in yeast, too. Interaction experiments have shown that pig 
heart mitochondrial Mdhp and yeast Citp bind to the yeast inner membrane. Binding is also 
observed as when both proteins are present at the same time. Therefore it can be supposed that 
in the yeast inner membrane there are at least two distinct binding sites, one specific for 
mitochondrial Mdhp, and the other for Citp (Brent and Srere, 1987). This binding is not 
restricted to yeast mitochondria. It was also observed in the inner membrane of a wide variety 
of mammalian species (Moore et al., 1984). Binding of matrix enzymes, especially of citrate 
synthase, to the mitochondrial inner membrane seems to be widespread providing evidence 
for its physiological relevance. If mitochondrial Citp and Mdhp from yeast are located at the 
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mitochondrial inner membrane, then binding of both protein to mitochondrial mRNAs could    
guarantee a vicinity of these RNAs to their specific translational activators. 
While increasing amounts of COX2 leader RNA clearly inhibit the Idhp enzyme activity, this 
was not found for Cit1p and Mdh1p enzyme activity (data not shown). The results do not 
point to an interdependence of enzymatic activity and RNA-binding property of these two 
enzymes and do not suggest a reciprocal regulation between metabolic activity and RNA-
binding. But does it mean that the RNA-binding is not relevant in vivo and is perhaps an 
evolutionary relict? The finding that Idhp binds in vitro much more sensibly to mitochondrial 
mRNAs than concomitant Cit1p and Mdh1p (data not shown) could support this idea. Since 
there are at least 25000 copies of Idhp per cell (Dekker et al., 1991) and the steady-state 
concentration of mitochondrial mRNAs in derepressed growth conditions, is approximately 
100 to 500 copies per transcript per cell (Müller and Getz, 1986), Idhp has the capacity to 
complex all mRNA molecules present. In mammals it could not be shown that Idhp binds to 
complex I and is located near the mitochondrial inner membrane, because of its instability in 
the course of preparation (Sümegi and Srere, 1984). Recently, however, an interaction of 
Idh2p with Cit1p and Mdh1p was reported (Grandier-Vazeille et al., 2001). This opens the 
possibility that Idhp reveals the same location as Cit1p and Mdh1p. Therefore directing of 
mitochondrial mRNAs to the translational machinery could be achieved by Idhp, too. In view 
of a complex formed by the Krebs cycle enzymes it can be speculated that this complex 
allows regulatory interactions that provide a more favourable condition for enzymatic activity 
(Robinson et al., 1987). Although the in vitro RNA-binding of Idhp does not require Cit1p or 
Mdh1p it could be possible that this complex provides in vivo conditions which allow or 
support the binding of specific RNA species. Thus, a highly integrated interplay among 
different metabolic pathways can be formed. 
4.5 Localisation of Cit1p and Mdh1p 
The exact structure of the Krebs cycle complex has still to be resolved; however there are 
compelling in vitro evidences that, in mammalian mitochondria, a channelling process occurs 
between consecutive enzymes of the Krebs cycle such as fumarase and malate dehydrogenase 
(Beeckmans et al., 1989) or malate dehydrogenase and citrate synthase (Robinson et al., 
1987; Lindbladh et al., 1994). This channelling is related to probable physical contacts bet-
ween the enzymes (Morgunov and Srere, 1998). Using a 5-fluortryptophan-labelled Cit1p, 
Haggie and Brindle (1999) have shown by 19F NMR that citrate synthase is motionally 
restricted in yeast mitochondria, consistent with its participation in a multienzyme complex. 
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In vivo demonstrations of channelling between citrate synthase and malate dehydrogenase 
(Lindbladh et al., 1994), citrate synthase and aconitase (Velot and Srere, 2000) provided 
further evidence that Cit1p interacts in vivo with Mdh1p and Aco1p. Probably Cit1p plays a 
key structural role in cycle function which is independent of its catalytic function, since an 
introduction in cit1 null mutant cells of a catalytically inactive but structurally unchanged 
Cit1p resulted in restoration of Krebs cycle function and growth on acetate (Kispal et al., 
1989). 
In view of the metabolic connection and their location it is possible that the Krebs 
cycle and the mitochondrial respiratory chain form a supracomplex. First the Krebs cycle 
gene-rates NADH which is the source for the respiratory chain to generate energy by 
producing ATP causing a functional and maybe physical linkage. Second all of the enzymes, 
previously thought to exist in a soluble form in the mitochondrial matrix, bind to the inner 
surface of the mitochondrial inner membrane, where the respiratory chain is located, while 
purified isozymes from other cellular compartments do not possess such binding abilities 
(reviewed by Srere et al., 1987). 
To check whether the yeast mitochondrial Krebs cycle enzymes form a complex or are 
components of other mitochondrial complexes 2D Blue native gel-electrophoresis was 
performed. The functionally active HA-tagged forms of Cit1p and Mdh1p which are able to 
confer growth on acetate were located in a complex smaller than 250 kDa. Possibly the weak 
interactions between the enzymes that are favoured in vivo by the very high protein 
concentrations in the mitochondrial matrix (Aragon and Sols, 1991; Minton et al., 1992) are 
disrupted by the dilutions that occurs during extraction of mitochondria. Another reason for 
the disruption of protein-protein interactions could be the choice of the detergent used for 
solubilisation. Possibly milder detergents as laurylmaltoside in lower concentration would 
allow the detection of the proposed metabolon. Since five of the Krebs cycle enzymes 
(fumarase, malate dehydrogenase, citrate synthase, aconitase and isocitrate dehydrogenase) 
from E. coli could be isolated as a high molecular weight complex (Barnes and Weitzman, 
1986), the same is conceivable for the yeast proteins. Indeed, the separation of yeast 
mitochondrial complexes by colorless native polyacrylamide gel-electrophoresis led to the 
first detection of a membrane associated complex (Grandier-Vazeille et al., 2001). It contains 
four Krebs cycle enzymes (Cit1p, Sdh1p, Fum1p and Mdh1p) and the matrix-facing NADH 
dehydrogenase Ndi1p. This opens new stratagies concerning the isolation of intact complexes 
from the cell and concerning the identification of new components associated with membrane 
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complexes. Eventually these methods lead to an confirmation of the Krebs cycle metabolon 
concept. 
4.6 Specifity of RNA-binding 
RNA mobility shift and competition assays were used to demonstrate that Cit1p and Mdh1p, 
purified from yeast mitochondrial extracts, bind specifically to the COX2 5’-leader RNA 
(3.6). In order to examine RNA-binding properties of highly purified Cit1p and Mdh1p a 
purification scheme was established by C-terminal fusion of the coding regions of Cit1p and 
Mdh1p from S. cerevisiae to a series of six histidine residues. It was shown by 
complementation analysis and enzyme assays that the carboxyl-terminal tags did not influence 
the function of these enzymes. Both proteins could be purified using affinity chromatography. 
This approach confirmed the ability of Cit1p and Mdh1p to dimerise because two bands, 
probably the histidine-tagged and the wild type form, were detected. This dimerisation in 
mitochondria was indicated by immunodetections of HA-tagged Cit1p and Mdh1p in 2D Blue 
native gel-electrophoresis, too (3.5.4). Several proteins are already known which require 
homomerisation to allow binding to RNA. Thus, it could be shown that the hnRNPC protein 
(heterogeneous nuclear ribonuclein particles) has to form homomeric complexes to get RNA-
binding property. The hnRNPC protein belongs to the core proteins which bind as particle 
forming complexes to the pre-mRNA in vertebrates during transcription (Tan et al., 2001). In 
E. coli it could be shown that BglG, an RNA-binding transcription anti-terminator, binds as 
dimer to the RNA (Boss et al., 1999). Therefore it is conceivable that Cit1p and Mdh1p have 
to dimerise, too. 
The histidine-tagged variants of Cit1p and Mdh1p are able to bind to COX2 leader RNA 
(3.5.5). Moreover, in titration assays aimed at establishing a working protein concentration, 
saturation of the RNA-binding sites was achieved. Whereas binding of a protein to a single 
RNA site shows a single shifted band multiple shifted bands were observed. These probably 
correspond to the sequential filling of multiple binding sites as the protein concentration is 
increased. Since an intermediate sized shifted band was absent it can be assumed that the 
binding sites are filled almost simultaneously, indicating strong cooperativity. If multiple 
binding sites on the particular small RNA molecules are present the analysis will be more 
complicated. For a further characterisation of the supposed multiple binding sites binding 
studies on truncated RNA sequences have to be performed. The identification of smaller 
RNA-binding fragments would then allow mutational alteration and could be used to 
determine the identity and binding affinity of each individual binding site. 
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The established working protein concentration seems to represent a molar excess to the COX2 
leader mRNA because increasing amounts of the labelled RNA led to an enhanced signal of 
bound RNA. This fact may explain why in competition experiments using increasing amounts 
of cold COX2 leader mRNA the same RNA started to compete only at a 50 fold molar excess. 
Calculations of the molar ratios yielded a ratio of 1 to 2 between protein (2.5 pmol) and RNA 
(5 pmol). This could be interpreted that 1 protein molecule binds to 1 RNA molecule which 
would be in contrast to the observed saturation of RNA-binding. Concerning a cooperative 
binding it could also be interpreted that there are 2 protein molecules binding to 1 RNA 
molecule and 1 of the protein molecules dissociates. Thus it could point to 2 RNA-binding 
sites, too. For an easier interpretation it is advisable to use competitor RNA at a level 
comparable to or greater than the input protein. 
The antisense transcripts from the same RNA sequences are expected to have extensive 
secondary structures. Usually single stranded loops whose size and position are identical in 
sense and antisense are formed. Since Cit1p and Mdh1p had the same affinity for the sense as 
for the antisense RNA of the COB leader and the COX2 leader/gene (3.6) both proteins seem 
to be secondary structure-specific in their ability to bind RNA. Gel shift analysis using COB 
leader and COX2 leader/gene RNA as competitors implied that Cit1p and Mdh1p could 
exhibit a more general RNA-binding ability (3.6). This could probably be related to the length 
and the number of certain secondary structures which could offer multiple binding sites. The 
finding that the tested RNAs compete in the order of their lengths: COX2 leader/gene RNA > 
COB leader RNA > COX2 leader RNA may also imply a higher affinity. In summary Cit1p 
and Mdh1p bind specifically to all three RNA types. 
Since all these RNAs have different sizes (from 104 nt for COX2 leader until 810 nt for COX2 
leader/gene) and can presumably fold in different alternative secondary structures, additional 
studies are needed to elucidate the sequence/structure requirements for Cit1p/Mdh1p binding. 
In an attempt to identify common secondary structures, RNA structures were generated for  
30°C by using the programm mfold 3.0 (http://mfold2.wustl.edu/~mfold/rna/form1-2.3cgi) 
with default parameters (Mathews et al., 1999; Zuker et al., 1999). One predicted stem loop 
structure which contains a “four” loop and a stem of 5 base pairs could be identified both in 
the COX2 leader RNA and in the COB leader RNA. Similar structures with longer stems were 
predicted for COB leader RNA and COX2 leader/gene RNA. In addition COB leader RNA 
and COX2 leader/gene RNA show a “five” loop and a stem of 6 base pairs. Possibly these 
secondary structures were recognised by Cit1p and Mdh1p, but it cannot be excluded that 
other, may be relatively short sequences are involved in that recognition. 
Discussion 
 72 
 
The mRNA sequence of the first six codons specifying the Cox2p leader peptide plays an 
important role in positively controlling translation (Bonnefoy et al., 2001). Data about binding 
of the Cit1p and Mdh1p to this sequence could help to develop a model of the RNA-binding 
function. 
First of all the RNA regions recognised by Cit1p and Mdh1p should identified. Chemical 
probing as a convenient and rapid approach could be used to identify nucleotides that are 
involved in protein binding. The most common strategies employed in chemical probing are 
footprinting and modification-interference analysis. In footprinting experiments, nucleotides 
that are protected from chemical attack in the presence of a bound protein are identified. In 
modification-interference experiments, nucleotides whose modification prevent protein bin-
ding are identified. Interpretation of RNA footprinting experiments is inherently ambiguous. 
A diminished reactivity of a nucleotide in response to binding of a protein to RNA can be due 
either to direct interaction of the protein with the protected nucleotide, or to a protein-induced 
conformational change in the RNA. Happily, both interpretations are interesting; however, it 
can often be difficult to distinguish between the possibilities. 
To detect and analyse RNA-protein interactions in vivo the three-hybrid system provides a 
rapid and potentially versatile method. In the three-hybrid system, a hybrid RNA functions as 
the bridge between two hybrid proteins. Hybrid protein 1 contains RNA-binding domain 1 
which is fused to a DNA-binding domain. Hybrid protein 2 contains a different RNA-binding 
domain, 2, which is fused to a transcription activation domain. The hybrid RNA contains re-
cognition sites for the two RNA-binding domains. The interaction of this RNA with the two 
hybrid proteins is required for transcription of the reporter gene. While this assay possesses 
many features of the two-hybrid system for the analysis of protein-protein interactions, hybrid 
RNAs differ from hybrid proteins in significant aspects. The structures formed by these RNAs 
may often not be physiological, since the same RNA sequence placed into different contexts 
can adopt different conformations. However, local, relatively stable structures, such as those 
recognised by the iron regulatory protein 1 (Irp1p) form even in unnatural contexts so as to be 
recognised by their cognate protein, and can coexist in a single RNA molecule in vivo 
(Sengupta et al., 1996). The stem-loop structures of these RNA elements are relatively stable. 
“Unstructured” RNAs might rather be able to form unproductive, alternative conformations, 
and could in principle limit the range of RNA-protein interactions that can be assayed. 
However, the formation of correct structures in only a fraction of the RNA molecules likely is 
sufficient to lead to transcriptional activation. 
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Despite the proven success of the method, it does not directly provide information about the 
physiological relevance of the interactions, since nuclear localisation of the interacting 
partners is required to obtain reporter gene expression. Moreover, many proteins (e.g. proteins 
with targeting sequences for other organelles) may not be amenable to this localisation, or the 
nuclear context may not be appropriate to detect some interactions that physiologically occur 
in another organelle. Indeed, alternative systems have been developed for analysis of 
interactions in cellular compartments other than the nucleus, but again, most of the 
interactions are detected out of their physiological context. 
An alternative system the fluorescence resonance energy transfer (FRET) has been used for 
analysing ribosome function (Hardesty et al., 1992). In the course of translation, for instance, 
changes in distance between two tRNAs or a tRNA and a ribosomal protein in the assembled 
tRNA-ribosome complex were observed (Odom et al., 1990). Likewise, the topology of 
ribosome-bound messenger RNA with respect to the 3’ end of 16S ribosomal RNA was 
evaluated by labelling the 5’ or 3’ end of various mRNA fragments with one and the 3’ end of 
16S rRNA with the other fluorophore of a FRET pair (Bakin et al., 1991; Czworkowski et al., 
1991). In principle, the donor-acceptor distances obtained can be used as constraints in 
molecular modelling of the underlying RNA architecture in the absence of a high-resolution 
NMR or crystal structure (Tuschl et al., 1994; Malhotra et al., 1994). The versatility of the 
fluorescence labelling and analysis techniques very likely will lead to an increasing popularity 
of FRET in the “RNA World”. 
4.7 Influence of cofactors and substrates on RNA-binding 
The combination of a great variety of irregular structures in RNA and the ease with which 
some of these can be deformed suggests that RNA-binding proteins will use a greater range of 
binding strategies than DNA-binding proteins and that “indirect readout” will be widespread. 
Therefore the number and kind of RNA-binding domains may also be widespread. 
Many regulatory proteins which bind to nucleic acids contain conserved structural domains 
such as the RNP motif, the RGG box, or the KH motif (Mattaj, 1993; Burd and Dreyfuss, 
1994). But the amino acid sequence of Cit1p and Mdh1p indicate that the RNA-binding 
domain of Cit1p and Mdh1p is distinct from the well characterised RNA-binding motifs. 
Since both proteins are involved in a biochemical pathway they are possibly in line with 
several other enzymes which also bind RNA and do not contain recognisable RNA-
recognition motifs. Some representatives of these bifunctional proteins are dehydrogenases 
containing a Rossmann fold like glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 
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glutamate dehydrogenase (GDH); some are (di)nucleotide binding proteins like members of 
the mammalian heat shock protein 70 (Hsp70p) family. All these enzymes, including Cit1p 
and Mdh1p, do however contain a (di)nucleotide binding domain. RNA-binding of GAPDH, 
GDH and Hsp70p could be competed by NAD(H), NADP(H) or ATP (Nagy and Rigby, 
1995; Henics et al., 1999) and prevented by the use of deletion mutants lacking the 
(di)nucleotide binding region (Henics et al., 1999; Nagy et al., 2000). These findings suggest 
that the (di)nucleotide binding domain serves as an RNA-binding domain, and indicate that 
the enzymatic function and RNA-binding are mutually exclusive. These observations led to 
the hypothesis that the RNA-binding domain present in these enzymes evolved from a 
(di)nucleotide binding site, or vice versa (Hentze, 1994). 
A possible involvement of the (di)nucleotide binding domains of Cit1p and Mdh1p in RNA-
binding was examined by competition experiments with the corresponding cofactors (3.7). 
While NAD, NADH and AMP did not inhibit, ATP competed for RNA-binding. This could 
be a hint at a structural motif responsible for recognition of ATP and distinct from the 
Rossmann fold which is involved in RNA-binding. The idea of a Rossmann fold-independent 
RNA-binding activity was already presented by Siep (2001) and supported by the finding that 
the RNA-binding capacity of Idhp was not affected by high concentrations of NAD+ and of 
AMP. The demonstration that another adenine-containing ligand, acetyl coenzyme A, is also 
able to diminish the specific RNA-binding activity of Cit1p and Mdh1p confirms that 
possibly an adenine-binding motif enables the binding to RNA. To test whether one or two 
adenine-binding motifs are present ATP and concomitant acetyl coenzyme A should be 
compete. If the competing concentration is the same like needed for the competition of ATP 
or acetyl coenzyme A two motifs are present. If the competing concentration is lower than 
needed for the competition of ATP or acetyl coenzyme A one motifs is present. However, a 
unique adenine-binding motif was recently identified in nearly one-third of the structurally 
defined ATP-dependent proteins and belonging to 12 different fold families (Denessiouk and 
Johnson, 2000). This motif uses the same structural elements to recognise adenine, regardless 
of whether the ligand is a coenzyme, cofactor, substrate or an allosteric effector (Denessiouk 
et al., 2001). Thus, in the group of CoA-dependent proteins Citp from the Antarctic bacterium 
DS2-3R, Pyrococcus furiosus, and Gallus gallus and in the group of NAD(P)(H)-dependent 
proteins Idhp from E. coli could be identified. This adenine-binding motif is present in 
“ancient proteins” common to all presentday organisms, suggesting that adenine-containing 
ligands and the common motif for binding them were exploited very early in evolution. 
Therefore it is conceivable that Cit1p, Idhp and Mdh1p from S. cerevisiae might also contain 
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this motif. The existence of such a motif could be examined by crystallisation of Cit1p and 
Mdh1p and analysis of their three-dimensional structures. Evidence for the involvement in 
RNA-binding could be obtained by the construction of respective deletion mutants. 
Although the Rossman fold was a good candidate for a RNA-binding domain, other 
sequences and/or structures seem to mediate the observed RNA-binding of Mdh1p. Therefore 
the presence of a Rossmann fold in combination with an RNA-binding property without 
further studies cannot be interpreted as a strong implication of the Rossmann fold as a general 
RNA-binding domain as suggested by Nagy and coworkers (2000). Malate dehydrogenase 
from pig liver is able to bind the IFNγ 3’-UTR RNA. It remains to be analysed whether the 
Rossmann fold really mediates this RNA-binding. 
An adenine-binding motif as an RNA-binding domain could also provide the regulatory 
linkage between the need for mitochondrial function and the rate of biogenesis, and would 
explain the combination of enzyme and RNA-binding activities in three single proteins from 
the same biochemical pathway. While the enzymatic function of Idhp seems to be regulated 
by binding of RNA (Anderson et al., 2000), in the case of Cit1p and Mdh1p such a regulatory 
mechanism was not detected (data not shown). Therefore it is conceivable that sequence or 
structural elements which are not related to the enzymatic function are responsible for the 
RNA-binding property. In order to identify an RNA-binding region in Cit1p and Mdh1p the 
respective amino acid sequences from S. cerevisiae and K. lactis should be compared. This 
sequence comparison has already led to the identification of amino acids important for the 
RNA-binding of Idhp and could also show some interesting amino acid differences in 
conserved regions of Cit1p and Mdh1p. By means of site-directed mutagenesis mutant 
proteins can be engineered and used to study the role of RNA-binding by Cit1p and Mdh1p in 
mitochondria.  
It has to be noted that ATP can chelate the Mg2+ ions in the binding assays and that lack of 
Mg2+ ions could prevent protein-RNA interaction. To exclude this possibility binding studies 
with increasing amounts of Mg2+ ions should be performed. 
However, the data presented here imply that in addition to the known classes of RNA-binding 
proteins (with either RNA recognition motifs or a Rossmann fold), there might be a novel 
class of RNA-binding proteins. 
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4.8 Role of Cit1p and Mdh1p as RNA-binding proteins 
RNA-binding proteins have been implicated in numerous different cellular processes like 
transcription, RNA processing and splicing, RNA stability, storage and transport of RNA, and 
different steps in translation. Cit1p and Mdh1p interact specifically with probably well 
defined RNA structures or elements, but with an lower affinity than Idhp. 
Following the idea that Cit1p and Mdh1p are involved in creating an environment necessary 
for Idhp RNA-binding they might have a role as “RNA chaperones” like suggessted for the  
70 kDa heat shock protein (Hsp70p) (Henics et al., 1999). Hsp70p and likely other 
chaperones may facilitate, through direct RNA-binding, the unwinding of complex secondary 
structures. This would aid in the exposure of critical cis-acting sequences for other protein 
factors to bind and, hence, allow proper and efficient assembly of polysomes. Such “nucleic 
acid chaperone” function had been designated to other non-chaperone proteins, such as 
nucleocapsid proteins of RNA viruses (Rein et al., 1998), heteronuclear ribonucleoprotein A1 
(Dreyfuss et al., 1993; Hamilton et al., 1997), and glyceraldehyde-3-phosphate 
dehydrogenase (Nagy and Rigby, 1995). Alternativley, Hsp70p and Hsp110p may also 
function in modulating the interaction of a given mRNA with regulatory proteins that can 
influence mRNA stability and/or translation. In support of this, Scandurro and co-workers 
(1997) have recently suggested that Hsp70p is a potent regulator of complex formation 
between the 3’-UTR of erythropoietin mRNA and its specific binding protein, erythropoietin 
mRNA-binding protein. Hsps and Cit1p and Mdh1p may bind specific mRNAs, mediating an 
“RNA chaperone” function that might be required for proper folding of the RNA to expose 
critical motifs to regulatory proteins. Alternatively, these chaperones may be required in the 
fine regulation of messenger ribonucleoprotein complex formation with other RNA-binding 
proteins, through the modulation of their folding state or facilitation of their 
microcompartmentation. It is also possible that direct protection of RNA and/or stabilisation 
of RNA-protein complexes by chaperones are relevant mechanisms during various stress 
conditions. 
The physiological role of an intramitochondrial RNA-binding of Cit1p or Mdh1p might 
further be supported by the variations of protein levels corresponding to the growth 
conditions. Transcription of CIT1 and MDH1 is repressed by glucose, a carbon source which 
does not require a mitochondrial function. But during the diauxic shift transcription of both 
genes is induced consistent with a requirement of a functional mitochondrion. Possibly these 
changes do not only reflect a general correlation between the mitochondrial protein levels but 
also an interdependence of RNA-binding activity and expression of respiratory chain 
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components. So, transcription of PET494, encoding a translational activator of Cox3p, is also 
repressed by glucose (Marykwas and Fox, 1989). Furthermore Pet494p is regulated by 
oxygen availability: anaerobically grown cells show one-fifth the level of expression in 
aerobically grown cells (Marykwas and Fox, 1989). Pet494p might modulate COX3 
translation in response to these conditions. Conditions which reveal a physiological relevance 
of the RNA-binding by Cit1p and Mdh1p have yet to be determined. 
It has been proposed that metabolic RNA-binding enzymes participate in general regulatory 
circuits linking a metabolic function to a regulatory mechanism, similar to the situation of the 
metabolic enzyme aconitase, which also functions as an iron-responsive RNA-binding 
regulatory element (Constable et al., 1992; Hentze, 1994). However, some workers have 
cautioned that some of these types of enzymes may merely represent “molecular fossils” of 
the transition from an RNA to a protein world and that the RNA-binding properties may not 
have a functional significance (Kyrpides and Ouzounis, 1995). Determination of the role, if 
any, of RNA-binding by Cit1p and Mdh1p must await further studies. 
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5 SUMMARY 
The work presented in this thesis aimed at shedding more light on translational control 
through protein-binding to mRNAs in yeast mitochondria. As in other eukaryotes, yeast 
mitochondria are essential cell organelles. Most of the energy required for all cellular 
processes is derived from reactions taking place in mitochondria and key enzymes for major 
metabolic routes are localised in this organelle. Impaired function of the mitochondrion 
underlies a wide spectrum of degenerative diseases in man. So, a better understanding of 
mitochondrial biogenesis in yeast is likely to provide valuable information about 
mitochondrial dysfunction in man and other organisms. 
 
1. Isocitrate dehydrogenase (Idhp) acts as a repressor of mitochondrial translation. Possible 
interactions with other proteins involved in translation or assembly were investigated in this 
work. Moreover the effects of Idhp mutations were analysed. 
 
By means of Blue native gel-electrophoresis it was shown that Idhp is in a complex of 
molecular weight larger than the cytochrome c oxidase (250 kDa). Since Idhp is able 
to form homomers, these data indicate that multimers of Idhp are present in that 
complex. 
 
The RNA-binding deficient protein Idh1pK182L/Y184N is able to substitute the wild type 
Idh1p and to complement a ∆idh1 strain despite the reduced level of Idh1p. The 
pattern of mitochondrially synthesised proteins and the level of Cox3p is not affected 
in respective mutants.  
 
The enzymatic mutant protein Idh1pS92A is not able to substitute the wild type Idh1p. 
The level of Cox3p and Idh1p is reduced in the respective mutants. The lack of Idh1p 
as well as the S92A mutation of Idh1p lead to a respiratory growth deficiency and 
result in a reduced steady-state level of mitochondrially encoded proteins.  
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2. Two novel RNA-binding proteins, Citrate synthase 1 (Cit1p) and Malate  
dehydrogenase 1 (Mdh1p), were identified. Both proteins do not contain known RNA-
recognition motifs. These Krebs cycle enzymes were examined for possible protein-protein 
interactions, specifi-city of RNA-binding, influence on translation and steady-state levels of 
mitochondrially encoded proteins. 
 
Under the condition of Blue native gel-electrophoresis protein-protein interactions of 
Cit1p and Mdh1p with other mitochondrial proteins were not detected. 
 
Preincubation of Cit1p and Mdh1p with a high molecular excess of heterologous 
competitor RNA or tRNA did not prevent complex formation with COX2 leader RNA. 
Therefore it can be concluded that Cit1p and Mdh1p specifically bind to COX2 leader 
RNA. 
 
RNA-binding at high salt concentrations (200 mM) may indicate that the protein-RNA 
interactions are not exclusively mediated by electrostatic interactions. The Heparin 
sensitivity of the RNA-binding by Cit1p and Mdh1p may indicate the involvement of 
hydrophobic interactions. 
 
Translation and steady-state levels of mitochondrially encoded proteins are not 
affected in ∆CIT1 and ∆MDH1 strains indicating that Cit1p and Mdh1p play no 
essential role in mitochondrial protein synthesis. 
 
In competition experiments the binding of Cit1p and Mdh1p to the labelled COX2 
leader RNA was inhibited in the order: COX2 leader/gene > COB leader > COX2 
leader RNA. COB leader and COX2 leader/gene antisense transcripts had the same 
affinity for the proteins like the sense RNAs. Therefore the secondary structure of 
mitochondrial mRNAs may define the target site of Cit1p and Mdh1p. 
 
In competition experiments the binding of Cit1p and Mdh1p to the labelled COX2 
leader RNA was inhibited by the substrate acetyl-CoA and the cofactor ATP. Other 
substrates or cofactors did not compete at the concentration of 5 mM. 
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